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I N T RODUC T I ON
Arteries are lined by endothelial cells and are wrapped 
by one or more layers of smooth muscle (SM) cells. 
There are electrical coupling and chemical signaling 
between SM cells and between SM cells and endothelial 
cells, and SM cells receive numerous neurotransmitter, 
endocrine, and paracrine signals that promote either 
contraction or relaxation. Independently of these sig-
nals, arterial SM cells respond autonomously to changes 
in sarcolemmal stretch caused by changes in intravascu-
lar pressure (McCarron et al., 1989). This phenomenon 
is called “myogenic reactivity.” It has an early phase called 
the “myogenic response” and a sustained phase called 
“myogenic tone.” The overall effect is to control lumi-
nal diameter in the face of changing luminal pressure. 
It is a vital background activity on top of which the many 
other stimuli have their effects.
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Abbreviations used in this paper: BK, large-conductance, voltage- and 
Ca2+-activated K+; Ca, Ca2+; Cain, sarcoplasmic Ca2+ concentration; CaV, 
voltage-dependent Ca; Cl, Cl; ClA, Ca-activated Cl; DAG, diacylglycerol; 
EET, 11,12-epoxyeicosatrienoic acid; K, K+; Na, Na+; NCX, Na–Ca ex-
changer; NO, nitric oxide; rms, root mean square; SERCA, sarcoplasmic/
endoplasmic reticulum Ca2+-ATPase; SM, smooth muscle; STOCs, sponta-
neous, transient outward currents; TRP, transient receptor potential; Vm, 
membrane potential.
The myogenic response is regulated by opposing cir-
cuits: one promoting an increase in sarcoplasmic Ca2+ 
concentration (Cain) and thereby an increase in tension 
and one promoting the opposite. Both circuits use Ca2+ 
(Ca) as a signal (Hill-Eubanks et al., 2011). The dual roles 
of Ca as a signal both for contraction and relaxation 
depend on the physical separation of opposing path-
ways afforded both by SM cellular architecture (Moore 
et al., 2004; van Breemen et al., 2013) and the widely 
different Ca sensitivities of the circuit-specific compo-
nents. In the SM sarcoplasm, Cain varies between 100 
and 400 nM, over which range myosin light chain ki-
nase activity goes from low to half-maximal (Stull et al., 
1998), and tension from low to maximal (Hill-Eubanks 
et al., 2011). The stretch-induced rise in Cain depends 
on the activity of voltage-dependent Ca (CaV) channels, 
principally those containing CaV1.2 (Moosmang et al., 
2003; Navedo et al., 2007).
The activation of CaV channels is opposed by the hy-
perpolarizing activity of large-conductance, voltage- 
and Ca2+-activated K+ (BK) channels. In the range of 
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Arterial smooth muscle (SM) cells respond autonomously to changes in intravascular pressure, adjusting tension 
to maintain vessel diameter. The values of membrane potential (Vm) and sarcoplasmic Ca2+ concentration (Cain) 
within minutes of a change in pressure are the results of two opposing pathways, both of which use Ca2+ as a signal. 
This works because the two Ca2+-signaling pathways are confined to distinct microdomains in which the Ca2+ con-
centrations needed to activate key channels are transiently higher than Cain. A mathematical model of an isolated 
arterial SM cell is presented that incorporates the two types of microdomains. The first type consists of junctions 
between cisternae of the peripheral sarcoplasmic reticulum (SR), containing ryanodine receptors (RyRs), and the 
sarcolemma, containing voltage- and Ca2+-activated K+ (BK) channels. These junctional microdomains promote 
hyperpolarization, reduced Cain, and relaxation. The second type is postulated to form around stretch-activated 
nonspecific cation channels and neighboring Ca2+-activated Cl channels, and promotes the opposite (depolariza-
tion, increased Cain, and contraction). The model includes three additional compartments: the sarcoplasm, the 
central SR lumen, and the peripheral SR lumen. It incorporates 37 protein components. In addition to pressure, 
the model accommodates inputs of - and -adrenergic agonists, ATP, 11,12-epoxyeicosatrienoic acid, and nitric 
oxide (NO). The parameters of the equations were adjusted to obtain a close fit to reported Vm and Cain as func-
tions of pressure, which have been determined in cerebral arteries. The simulations were insensitive to ±10% 
changes in most of the parameters. The model also simulated the effects of inhibiting RyR, BK, or voltage-activated 
Ca2+ channels on Vm and Cain. Deletion of BK 1 subunits is known to increase arterial–SM tension. In the model, 
deletion of 1 raised Cain at all pressures, and these increases were reversed by NO.
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80 Model of arterial smooth muscle myogenic response
Nelson (1998). The fit was achieved mainly by adjusting 
the numbers of molecules of each of the components, 
considered “global” parameters. There were not enough 
data to determine uniquely even the subset of parame-
ters adjusted to obtain this fit, and given the complexity 
of the mechanism, a unique set of fitting parameters 
might not be obtainable (e.g., Hines et al., 2014). Nev-
ertheless, the model simulated experimental data beyond 
those used to find the set of close-fit parameters, such as 
the effects of the block of key components on the rela-
tionships of Vm and Cain to pressure (Knot and Nelson, 
1998; Knot et al., 1998) and the effects of the knockout 
of the BK 1 subunit (Brenner et al., 2000; Dong et al., 
2008; Sachse et al., 2014). It also predicted the effects of 
selected vasoactive agents on the responses to pressure 
of an arterial SM cell after knockout of BK 1. In addi-
tion, the fit with plausible parameters of the model to 
experimental data demonstrated the feasibility of its 
speculative components as, for example, stretch-trans-
ducing microdomains.
MAT E R I A L S  AND  M E THOD S
Physical model. The model of an arterial SM cell (Fig. 1) includes 
compartments and components relevant to the control of Vm and 
Cain by intravascular pressure. It also includes the targets for a few 
exemplary endocrine and paracrine inputs to SM. The compart-
ments are the sarcoplasm (subscript “in”), the central SR (SRcen), 
the peripheral SR (SRper), the junctional microdomain (subscript 
“jun”), and the postulated stretch-transducing microdomain 
(subscript “str”). There are hundreds of junctional microdomains 
per SM cell (Moore et al., 2004) between the sarcolemma and ap-
posing peripheral SR cisternae. I assume that there are also a simi-
lar number of stretch-transducing microdomains. In my initial 
estimates of the rate constants for the relaxation by diffusion of 
concentration differences between these microdomains and the 
domains to which they are connected, their approximate dimen-
sions were taken into account. Otherwise, they were treated as 
single composite compartments with uniform concentrations and 
with volumes that are the sums of the individual microdomains.
Inorganic ions and second messengers. The key ion is Ca. Its 
concentrations in the different domains are Cain, Cajun, CaSRcen, 
CaSRper, and CaNSCstr. The microdomains are relatively small vol-
umes into which Ca influxes are transiently greater than Ca ef-
fluxes (Sobie et al., 2002). Both the stretch microdomains and 
the junctional microdomains have paths to the cytoplasm, and Ca 
in these domains equilibrates by diffusion with Ca in the sarco-
plasm (see supplementary equations Seqs. D1 and D3). Similarly, 
Ca in the SRcen equilibrates with Ca in the SRper by diffusion (Seq. 
D2). The cytoplasmic concentrations of Na, K, and Cl, designated 
“Nain,” “Kin,” and “Clin,” are also taken to be the concentrations in 
the other intracellular domains. All of the intracellular ion con-
centrations are functions of time (Seqs. J31 and J36–J41). The 
extracellular ion concentrations, Caex, Naex, Kex, and Clex, are 
fixed. The diffusible second messengers, cAMP, cGMP, and IP3, 
are distributed uniformly in the cytoplasm and in the stretch and 
junctional microdomains. Diacylglycerol (DAG), no doubt almost 
completely confined to lipid membranes, for simplicity is also 
treated as if it were soluble and uniformly distributed in all 
membrane potential (Vm) in SM cells, half-maximal ac-
tivity of BK channels requires tens of micromolar Ca 
(Jaggar et al., 2000), which is obtained in narrow junc-
tions between the peripheral SR and the sarcolemma 
(Moore et al., 2004; van Breemen et al., 2013). In these 
junctions, clusters of ryanodine receptors (RyRs) in the 
peripheral SR membrane are apposed to clusters of BK 
channels in the sarcolemma (Lifshitz et al., 2011). RyR 
releases Ca into the junctional gap, transiently raising 
the Ca concentration 10–100 times higher than that in 
the sarcoplasm (Jaggar et al., 2000), recruiting additional 
RyR activity and activating the apposed BK channels 
(Nelson et al., 1995). The junction is a microdomain, in 
which signaling is directed by proximity and the signal 
intensity is tailored to the sensitivities of the target com-
ponents (Neher, 1998; Berridge et al., 2003; Rizzuto 
and Pozzan, 2006; Neves and Iyengar, 2009; Santana 
and Navedo, 2009; van Breemen et al., 2013).
The initiation of the myogenic response requires its 
own microdomain, albeit one that does not, at least to 
date, have a defined subcellular structure. Stretch-acti-
vated sarcolemmal cation–conducting channels have not 
been definitively identified. In the current model, they 
are taken to be transient receptor potential (TRP) chan-
nels (Earley et al., 2004; Sharif-Naeini et al., 2009; Earley 
and Brayden, 2010). These deliver Ca to neighboring 
Ca-activated Cl (ClA) channels formed by TMEM16A, of 
which the half-maximal activation occurs at micromolar 
Ca (Bulley et al., 2012; Jin et al., 2014). The ClA channel 
current depolarizes the SM cell, activating CaV channels.
I present a model of the short-term, pressure-induced 
responses of an isolated arterial SM cell. In small arter-
ies, removal of the endothelium did not affect either 
pressure-induced responses or the block of key compo-
nents (Knot and Nelson, 1998). The model SM cell 
contains five interconnected compartments for Ca: the 
sarcoplasm, the central SR, the peripheral SR, the 
combined junctional microdomains, and the combined 
stretch-transducing microdomains (Fig. 1). The model 
includes 37 protein components located within the 
compartments or embedded in their bounding mem-
branes. The experimental evidence for the assigned roles 
and locations of the components is stronger for some 
than for others. The current model builds on previous 
models, none of which, however, included the junctional 
and the stretch-transducing microdomains or dealt with 
the myogenic response (Bennett et al., 2005; Yang et al., 
2005; Kapela et al., 2008). The current model has a large 
number of parameters (number of molecules of each 
component, rate constants, dissociation constants, per-
meabilities, etc.), of which only some were constrained 
by experimental results. Most of the unconstrained 
“local” parameters were adjusted to give plausible prop-
erties to the individual components. The model was 
closely fit to Vm and Cain as functions of intravascular 
pressure, determined in cerebral arteries by Knot and 
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(Dessauer and Gilman, 1997) (see supplementary reaction schemes), 
as governed by Seqs. J9, J10, and J46–J49. In the model, PKA inac-
tivates AC, representing feedback inhibition (Vandamme et al., 
2012). The time courses of the phosphorylated and dephosphory-
lated states are determined by Seqs. J8 and J49.
AR (-adrenergic receptor). 1AR is the predominant subtype 
in small resistance arteries (Garland et al., 2011). The reaction 
scheme (see supplementary reaction schemes) mirrors that for 
AR, except that AR activates Gs. The time courses are de-
termined by Seqs. J42–J45.
BK channel. BK channel consists of four pore-forming  subunits 
and four modulatory 1 subunits (Butler et al., 1993; Knaus et al., 
domains. The concentrations of the second messengers vary with 
time (Seqs. J2, J10, J21, and J29).
Protein components
AR (1-adrenergic receptor). AR binds -adrenergic agonist 
reversibly, activates Gq, and is phosphorylated, internalized, 
and recycled (Schöfl et al., 1993; Bennett et al., 2005). These pro-
cesses are represented as simplified reactions (see supplementary 
reaction schemes), the time courses of which are determined by 
Seqs. J11–J15 and J25.
AC (adenylate cyclase). AC6 is the major subtype involved in 
-adrenergic vasodilator signaling in arterial SM cells (Nelson 
et al., 2011). AC is activated by Gs_GTP and converts ATP to cAMP 
Figure 1. Scheme of model. A SM cell sarcolemma contains channels, receptors, and transporters shown as rectangles spanning the 
membrane. Enzymes are represented as circles or octagons. Membrane-bound substrate PIP2 and effector DAG are shown as ovals. 
A common Ca buffer (BUFFER) is uniformly distributed throughout the cell except in the central SR (SRcen) and the peripheral SR 
(SRper), in which the Ca buffer is uniformly CSQ. Inorganic ions are shown without their charges and subscripted to indicate their 
compartment. Subscript “ex” refers to the extracellular milieu, “in” refers to the sarcoplasm, “jun” refers to the junction between the 
SRper and the sarcolemma, “str” refers to the postulated Ca microdomain around the stretch-activated channel (NSCstr), “cen” refers 
to the central SR, and “per” refers to the peripheral SR. (The longer subscripts NSCstr, SRper, and SRcen are used in the text and in the 
program.) The components associated with the junction are highlighted in blue, and those associated with the stretch microdomain are 
highlighted in orange. Cain, considered uniformly distributed in the sarcoplasm except for the microdomains, is highlighted in black. 
Other soluble components and effectors are shown in bold lettering. Most components are shown once. The kinases are repeated to be 
close to their targets, and the inorganic ions are repeated to be close to their sources and sinks. All abbreviations are defined in Materi-
als and methods. A line ending in a closed arrowhead indicates activation; a line ending in a bar indicates inhibition. A closed arrow 
head pointing at an encircled Vm indicates depolarization, and a barred line indicates hyperpolarization. A line ending in a closed arrow 
crossed by a bar indicates activation followed by inhibition. A line ending in an open arrowhead indicates a flux between compartments 
or an enzyme reaction.
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Ca sites (Seqs. F1 and F3) and may also decrease the Ca affinity of 
the inhibitory sites (Taylor and Prole, 2012), although the latter 
effect is neglected here. ATP is a coregulator of the Ca affinity of 
the stimulatory sites (Mak et al., 2001), but because sarcoplasmic 
ATP concentration is assumed here to be constant, its effect on 
IP3R is implicit. PKG phosphorylation is modeled as suppressing 
IP3R activity by lowering its affinity for IP3 (Seqs. F2 and F4) 
(Desch et al., 2010). The time courses of the phosphorylated 
states are governed by Seqs. J50 and J51.The steady-state Ca flux 
and current are given by Seqs. F9–F12.
KATP (Kir6/SUR). KATP channels in resistance artery SM are acti-
vated by PKA, causing hyperpolarization and vasodilation, and 
inhibited by PKC, causing depolarization and vasoconstriction 
(Quayle et al., 1997; Aziz et al., 2012). Sarcoplasmic ATP, the con-
centration of which is assumed to be constant, acts as a low-affinity 
inhibitor. In the model, the open probability, PKATP_PKA, of PKA-
phosphorylated KATP is greater than PKATP of dephosphorylated 
KATP; Popen of PKC-phosphorylated KATP is assumed to be zero. 
Furthermore, phosphorylation by PKA and phosphorylation by 
PKC are assumed to be mutually exclusive. The time courses of 
the phosphorylated states are governed by Seq. J73-J75. The 
steady-state K flux and current are given by Seq. E37-E42.
KV (voltage-dependent K) channels. One type of voltage-depen-
dent K channel, with the properties of Kv1.5, is incorporated in 
the model (McGahon et al., 2007; Kapela et al., 2008; Hald et al., 
2012). The steady-state K flux and current are given by Seqs. E44 
and E45.
Leak channels Caleak, Clleak, and Kleak. These are postulated con-
ductors of background Ca, K, and Cl currents. The model has 
equations for a Na leak (Seqs. E50 and E51), but this leak was set 
to zero in all simulations presented here. The steady-state fluxes 
and currents are given by Seqs. E46–E54.
NaK (Na, K-ATPase). The relative driving force for transport is 
taken as the electrochemical free energy change for the transport 
of 3 mol of Na outward plus 2 mol of K inward plus the free energy 
change caused by the hydrolysis of 1 mol of ATP (µATP), all nor-
malized by µATP (Seq. G1). The net current depends on Hill func-
tions of Nain and Kex (Kapela et al., 2008) multiplied by the relative 
driving force and by the maximum NaK current per cell (Seq. G2).
NaKCl (Na-K-Cl cotransporter NKCC1). NaKCl is essential for the 
maintenance of the relatively high Clin in SM cells (Chipperfield 
and Harper, 2000). It is modeled as containing four ion-binding 
sites: one for Na, one for K, and two for Cl (supplementary reac-
tion schemes). There are two accessibility states: all sites facing 
outward and all sites facing inward. Isomerization between these 
states occurs only when all sites are empty or when all sites are 
occupied. These isomerizations are governed by rate constants. 
Ion binding to the sites is ordered in single file (first on, first off) 
(Lytle et al., 1998) and is governed by three equilibrium-binding 
constants. These are unchanged by changes in site accessibility. 
The steady-state net inward flux of the fully occupied transporter 
is given by Seq. G7 (derivation not shown). This model is based 
on that of Benjamin and Johnson (1997) but with fewer parame-
ters. Because the binding constants are the same in the two con-
formations, the isomerization rate constants are constrained by 
microscopic reversibility, as shown in Seq. G3. NaKCl transport is 
potentiated by PKC (Chipperfield and Harper, 2000), and in the 
model the rate constants for the isomerization of the occupied, 
phosphorylated NaKCl are multiplied by an enhancement factor 
(Seq. G8). The transport is suppressed by both PKA and PKG 
(Chipperfield and Harper, 2000), and in the model these kinases 
1994; Wang et al., 2002). The steady-state dependence of PBK on 
Vm (“v” in steady-state equations) and Cain (“c” in steady-state equa-
tions) (Seqs. E1–E3) is based on the model of Horrigan et al. 
(1999) as modified for the complex with 1 (Bao and Cox, 2005). 
The complex enhancement of BK channel activity by PKA and PKG 
and its suppression by PKC (Zhou et al., 2008, 2010) are repre-
sented simply by changes in LBK (Seqs. E6, E9, and E12). In the 
model, BK channel phosphorylation by one kinase blocks phos-
phorylation by another. The time courses of the phosphorylated 
states are governed by Seqs. J22–J24 and J27. The potentiation of 
BK channels by PKG and PKA via enhanced trafficking of 1 to the 
sarcolemma (Leo et al., 2014) is not included: the BK complex is 
assumed to contain a full complement of four 1 subunits.
BUFFER. BUFFER stands in for all protein and nonprotein Ca 
buffers in the sarcoplasm, junctions, and the stretch-transducing 
microdomains, and is assumed to be uniformly distributed.
CaV channel (voltage-activated Ca channel containing the 
CaV1.2  subunit together with additional subunits). CaV1.2-
containing CaV channel plays a dominant role in SM control of 
Ca and of tension (Moosmang et al., 2003). Steady-state Popen for 
CaV channel, called PCaV, increases with increasing Vm (Rubart 
et al., 1996) and decreases with increasing Cain (Zühlke et al., 1999) 
(Seqs. E17–E19). Potentiation of CaV channel activity by PKC phos-
phorylation (Navedo et al., 2006) is modeled as a negative shift in 
the midpoint of the dependence of PCaV on Vm, from VCaV for the 
dephosphorylated channel to VCaV_PKC (Seqs. E22 and E23). Sup-
pression of CaV channel activity by PKG phosphorylation (Yang 
et al., 2007) is modeled as a positive shift from VCaV to VCaV_PKG 
(Seqs. E26 and E27). The time courses of the phosphorylated states 
are governed by Seqs. J57–J59. The steady-state Ca flux and current 
are given by Seqs. E20 and E21, E24 and E25, and E28–E30.
ClA channel (TMEM16A). ClA channel contributes to the myo-
genic response in resistance-size cerebral arteries (Bulley et al., 
2012). Furthermore, ClA channel is activated by locally elevated 
Cain conducted by nearby nonspecific cation channels (Bulley 
et al., 2012), which are designated here as “NSCstr channels” and 
share the stretch-transducing microdomain with ClA channel in 
the model (Fig. 1). The EC50 for Ca decreases with depolariza-
tion, and the channel is inhibited by high Cain (Yang et al., 2008). 
These characteristics are represented by the steady-state equa-
tions for PClA (Seqs. E31–33). The steady-state Cl flux and current 
are given by Seqs. E34–E36.
CSQ (calsequestrin). CSQ stands in for all Ca buffers in the cen-
tral and peripheral SR.
Gq (Gq). Gq is primed by AR to exchange GTP for GDP. 
Gq_GTP activates PLC and slowly hydrolyzes bound GTP, a reac-
tion accelerated by PLC (Waldo et al., 2010) (supplementary re-
action schemes). Time courses of Gq forms are determined by 
Seqs. J14, J15, J17–J21, J25, J26, and J28.
Gs (Gs). Gs is primed by AR to exchange GTP for GDP. Gs_
GTP activates AC and slowly hydrolyzes bound GTP (supplemen-
tary reaction schemes), as governed by Seqs. J9, J42, and J45–J49.
IP3R (IP3 receptor, Ca release channel). These tetrameric Ca re-
lease channels are located principally in the SRcen membrane 
(Fig. 1) (Narayanan et al., 2012). IP3R contains stimulatory sar-
coplasmic Ca sites, inhibitory sarcoplasmic Ca sites (Seq. F5), and 
stimulatory luminal Ca sites (Seq. F6) (Bezprozvanny et al., 1991). 
Binding of IP3 increases the affinity of the stimulatory sarcoplasmic 
 o
n






Published June 29, 2015
 Karlin 83
NSCstr (stretch-activated nonspecific cation) channels. These 
channels share the stretch-transducing microdomains with ClA 
channels (see above). Several types of TRP channels, including 
TRPM4, are candidates for roles in the myogenic response to in-
tramural pressure (Sharif-Naeini et al., 2009; Earley and Brayden, 
2010), and the NSCstr channels might be hetero-oligomeric com-
plexes of TRP types (Earley et al., 2004). Because TRPM4 alone 
does not conduct Ca, it is unlikely to be the sole component of 
NSCstr channels. Piezo1 and Piezo2 are unlikely candidates for 
stretch-activated channels in SM: Piezo 1, half-maximally activated 
at 28 mm Hg and maximally activated at 60 mm Hg, is too sensitive, 
and Piezo 2 desensitizes too quickly (Coste et al., 2010). NSCstr 
channels are modeled as activated by stretch and DAG (Seq. E72), 
and both are activated (Seqs. E73–E75) and inhibited (Seq. E76) 
by CaNSCstr. Popen for NSCstr, called “PNSCstr,” is a product of these fac-
tors (Seqs. E77–E79). Potentiation by PKC (Earley et al., 2007) is 
modeled as a decreased EC50 (K.NSCstr_PKC_Ca_act) for activa-
tion by Ca (Seq. E74), and suppression by PKG (Takahashi et al., 
2008) is modeled as an increased EC50 (K.NSCstr_PKG_Ca_act) 
for Ca (Seq. E75). The time courses of the phosphorylated states 
are determined by Seqs. J70–J72. The steady-state Na, K, and Ca 
fluxes and currents are given by Seqs. E80–E105.
PDEcA and PDEcG (generic phosphodiesterases specific for 
cAMP and cGMP, respectively). These are modeled as activated 
by binding of their cognate substrate at an allosteric site, as de-
scribed by equilibrium Hill functions (Seqs. H1–H4) (Francis 
et al., 2011). They can be potentiated by both PKA and PKG 
(Vandamme et al., 2012). In the model, they each can be phos-
phorylated at a single site by either PKA or PKG (Fig. 1), and this 
phosphorylation increases the affinities of their allosteric sites. 
The time courses of phosphorylation are determined by Seqs. 
J62–J65. The cAMP and cGMP hydrolysis reactions are modeled 
as second order (Seqs. J2 and J10), i.e., at low extents of satura-
tion of the catalytic sites, as opposed to the allosteric sites.
PKA. The allosteric activation of PKA by cAMP is modeled as a 
Hill function with a Hill coefficient >1 (Herberg et al., 1994; 
Boettcher et al., 2011) (Seq. H5). In the model, all kinases are as-
sumed to be in one-to-one complexes with their targets (Santana 
and Navedo, 2009; Kholodenko et al., 2010; Gold et al., 2011; 
Schlossmann and Desch, 2011), with reaction rate constants spe-
cific for these targets.
PKC. This is a generic, conventional PKC requiring both DAG 
and Ca for activity (Nishizuka, 1995). The relative activity is mod-
eled as a product of two Hill functions (Seq. H6).
PKC. PKC is a DAG-dependent, Ca-independent subtype, 
which targets KATP (Aziz et al., 2012). Its relative activity is given 
by Seq. H7.
PKD. PKD is another DAG-dependent, Ca-independent subtype, 
which targets P2XR (Ase et al., 2005). Its relative activity is given 
by Seq. H8.
PKG. PKG is activated by cGMP, as given by Seq. H9.
PLC (PLC). PLC is activated by Gq_GTP and hydrolyzes PIP2 to 
DAG and IP3. In the model, PLC has low basal activity. PLC acts 
as a GAP and hastens the hydrolysis of GTP by Gq_GTP (Waldo 
et al., 2010). PLC activity is suppressed by both PKA and PKC 
(Yue et al., 2000; Huang et al., 2007), which is simplified in the 
model as direct phosphorylation of PLC resulting in the lowering of 
its affinity for Gq_GTP. These reactions are shown in supplementary 
activate a hypothetical protein phosphatase specific for PKC-
phosphorylated NaKCl. (This is a simplifying logical device per-
mitting just one NaKCl phosphorylation site.) The time courses 
of phosphorylation and dephosphorylation are governed by Seqs. 
J66 and J67. The net inward fluxes of Cl, Na, and K are given by 
Seqs. G10–G13. Notwithstanding that the sum of the Cl, Na, and 
K currents via NaKCl is zero, the Cl flux is also expressed as cur-
rent (Seq. G13) for convenient comparison with other currents.
NCX (Na–Ca exchanger). In one of three possible functional 
modes, NCX exchanges three Na for one Ca (Kang and 
Hilgemann, 2004). In a relatively simple model of this major mode 
(supplementary reaction schemes), NCX is activated by Cain binding 
cooperatively to regulatory sites (Seq. G15) (Reeves and Condrescu, 
2008). Furthermore, NCX has one transport site for Ca and three 
transport sites for Na. The transport Ca site and the Na sites 
are simultaneously accessible only on opposite sides of the mem-
brane. Association and dissociation are ordered: the three Na 
associate before the Ca and dissociate after the Ca. Binding is al-
ways at equilibrium. Only NCX with empty transport sites or with 
fully occupied transport sites can switch the accessibilities of the 
transport sites. In the model, unoccupied NCX has two net nega-
tive charges in its Ca transport site and three net negative charges 
in its three Na transport sites. When these unoccupied sites switch 
their accessibilities to opposite sides of the membrane, the equiva-
lent of one negative charge crosses the membrane, and the free 
energy changes by ±FVm, depending on the direction of trans-
port. No net charge is transported when the fully loaded sites 
switch their accessibilities. It is assumed that the effect of Vm is on 
the rate constants for switching accessibilities and that the transi-
tion state is halfway through the potential drop; thus, the rate 
constant for the isomerization for Na sites–out and Ca site–in 
to Na sites–in and Ca site–out, NCX_0, contains the factor 
exp[F*Vm/(2RT)], and the rate constant for the opposite isom-
erization, NCX_0, contains the factor exp[F*Vm/(2RT)] (sup-
plementary reaction schemes; Seq. G16). Microscopic reversibility 
applies to the isomerization rate constants at Vm = 0 (Seq. G14). 
In the steady state, the total fluxes of Na sites, both empty and 
occupied, in the two directions must be equal. This and the equi-
librium-binding equations yield the steady-state transport rate of 
three Na outward and one Ca inward minus three Na inward and 
one Ca outward (Seq. G19) and the net current (Seq. G20).
NSCeet (nonspecific cation channels activated by 11,12-epoxye-
icosatrienoic acid [EET], an endothelium-derived hyperpolarizing 
factor). NSCeet includes TRPV4, which acts as an EET receptor in 
a signaling microdomain with BK channel and RyR (Earley et al., 
2005, 2009). In the model, NSCeet is located in the junctional mi-
crodomains. EET binding activates NSCeet (Seq. E56). When acti-
vated, it increases Cajun, activating BK channel and RyR. TRPV4 is 
also activated by depolarization in the absence of ligand, but nPo is 
low at Vm of less than 40 mV (Loukin et al., 2010). One way to 
simulate both the V dependence of TRPV4 in the absence of EET 
and its significant activation by EET in the physiologically relevant 
range of Vm of less than 40 mV is to allow EET binding to shift the 
V50 to the left (Seq. E55). The steady-state Na, K, and Ca fluxes and 
currents are given by Seqs. E57–E63.
NSCne (receptor-activated nonspecific cation) channels. In mes-
enteric artery SM, NSCne channel is close to 1-adrenergic recep-
tors and activated by phenylephrine and by DAG, but not by PKC 
(Hill et al., 2006). NSCne channel is composed of TRPC6 and 
possibly TRPC3 or TRPC1 (Saleh et al., 2006). NSCne channel 
open probability is modeled as activated by DAG and both acti-
vated and inhibited by Cain (Seq. E64). The steady-state Na, K, 
and Ca fluxes and currents are given by Seqs. E65–E71.
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sGC (soluble guanylate cyclase). sGC is the target for nitric oxide 
(NO), modeled as in supplementary reaction schemes. The bind-
ing of one NO activates sGC; the binding of a second NO acceler-
ates this activation (Yang et al., 2005). Feedback inhibition of sGC 
by PKG (Murthy, 2004) is modeled as exclusive phosphorylation 
of the active state to yield an inactive state incapable of binding 
NO. Seqs. J2–J7 govern the time courses of the sGC states and the 
concentration of cGMP.
Mathematical representation
The core of the program is a solve block of 63 nonlinear ordinary 
differential equations and 18 algebraic equations (Seqs. J2–J82) 
that generate the time courses of 81 variables. These include Vm; 
the concentrations of Ca in all compartments; the concentrations 
of Na, K, Cl, cAMP, cGMP, IP3, and DAG; the states of occupation 
and activity of receptors for A, ATP, A, and NO; the states of 
AC, Gs, Gq, sGC, and PLC; the states of phosphorylation of all 
modulated components; and the states of occupation of Ca buf-
fers. The equations in the solve block call 180 steady-state equa-
tions (in which time is not an explicit argument) that determine 
for all channels and transporters their open-state probabilities or 
activities and the currents and fluxes conducted or transported 
by them and, in addition, the relative activities of all kinases and 
phosphodiesterases. The time courses of the applications of effec-
tors are described by functions (Seqs. C1–C16), the parameters of 
which are given in Table S1.
The equations were written and solved in PTC Mathcad 15.0 
M010. The differential equations and algebraic equations in the 
solve block were solved with the radau option for stiff differen-
tial equations. In a typical run with the normal parameter set 
(Table S6), the time courses over 300 s of 81 variables, and of 
additional functions of these variables, were solved at 6 values of 
intravascular pressure. For each variable (and functions of vari-
ables like fluxes and currents) at each intravascular pressure, 
12,000 points were retained for the calculation of mean values 
of the variables and for plotting. On a computer with an Intel 
Core i7-3770K cpu, calculations and plotting were completed in 
35 min.
Parameters
The equations of the model involved a large number of adjust-
able parameters (Table S6). Parameters that determined the be-
havior of the individual components were considered local; the 
parameters specifying the total numbers of molecules, or concen-
trations, or maximum currents of the components were considered 
global. Parameter values were (a) experimentally determined; 
(b) adjusted to give local model output that approximated the 
observed behavior of individual components; or (c) biochemi-
cally reasonable guesses calculated to give behavior of the compo-
nents consistent with their expected roles and, if rate constants, 
to give steady states within a few minutes. In case (a), the local 
models and their parameters were taken from the literature. 
Local models were extended to simulate the reported qualitative 
effects of phosphorylation. In case (b), the local model was differ-
ent from any published model, and its parameters could not have 
been obtained previously even if the experimental data existed. 
For some of these components, there are experimentally derived 
composite parameters such as EC50s, desensitization rates, and so 
on. For this subset of components, parameter values were initially 
adjusted to simulate the observed properties. These values, how-
ever, were often ballpark approximations because, for example, 
arterial constriction might have been determined experimentally, 
whereas the ultimate outputs of the model are Cain and Vm; fur-
thermore, these outputs are not determined by a single compo-
nent. Also, published experiments were performed with a variety 
of species, cell types, and conditions, and different values have 
been reported for the same composite parameter.
reaction schemes (-Adrenergic signaling), and the time courses 
are governed by Seqs. J16–J21.
PMCA (sarcolemmal Ca-ATPase). PMCA exchanges one Ca for 
one or more protons with the hydrolysis of one ATP (Brini and 
Carafoli, 2011). In the model, it is assumed that Ca/H is 1:1, so 
that the 1 net charge is transferred per cycle (Seq. G21). PMCA is 
disinhibited by Ca-calmodulin at Kd < 1 µM for Ca. This is simpli-
fied in the model as a dependence of activity on a Hill function 
in Ca (Seq. G22).
PP (generic protein phosphatase). PP is modeled to be in a com-
plex with each component that is a target of a kinase and to be 
constitutively active.
PP_NaKCl. This is a hypothetical protein phosphatase specific for 
NaKCl. PP_NaKCl is modeled as activated by PKA and PKC. This 
is a simple mechanism for the suppression of NaKCl activity by 
these kinases (Chipperfield and Harper, 2000). The time courses 
of PP_NaKCl and of PP_NaKCl_P are determined by Seqs. J68 
and J69.
P2XR (P2X1 receptor). This receptor is activated by ATP core-
leased with norepinephrine in pulses from proximal sympathetic 
nerve varicosities (Nausch et al., 2012) (see supplementary reac-
tion schemes). The rate constants of the upper cycle are con-
strained by microscopic reversibility. Desensitization is from the 
open state (Kaczmarek-Hájek et al., 2012), and PKD potentiation 
is modeled as increasing the rate of recovery from desensitization 
(Ase et al., 2005). The time courses of all forms are governed by 
Seqs. J76–J82. The steady-state Na, K, and Ca fluxes and currents 
are given by Seqs. E106–E112.
RyR (Ca release channel type 2). In the model, only RyR chan-
nels located in the peripheral SR are considered. RyR is both 
activated and inhibited (Seqs. F15 and F16) by Cajun binding to 
separate junctional sites (Bezprozvanny et al., 1991). Significant 
binding of Ca in the physiological range to the latter site likely 
involves calmodulin (Xu and Meissner, 2004), which is implicit in 
the model. RyR is potentiated by CaSRper binding to an SR-luminal 
site (Sobie et al., 2002; Launikonis et al., 2006). This potentiation 
is modeled as CaSRper lowering the dissociation constant of the 
activating junctional site (Seqs. F13 and F14). In the model, PKA 
potentiates RyR (Shan et al., 2010) by increasing the affinity of 
the activating site (Seqs. F17–F19). In contrast, PKC suppresses 
RyR (Liu et al., 2009; Peng et al., 2010) by decreasing the affinity 
for Cajun (Seqs. F20–F22). PKA and PKC phosphorylation are 
modeled as mutually exclusive. The time courses of the phos-
phorylated states are determined by Seqs. J54–J56. The steady-
state Ca flux and current are given by Seqs. F23–F27.
SERCA (Sarcoplasmic/endoplasmic reticulum Ca2+-ATPase). 
SERCA is restricted in the model to the central SR. It is activated 
by Cain and inhibited by CaSRcen (Wray and Burdyga, 2010) (Seq. 
G23). PKA, PKG, and PKC phosphorylate phospholamban caus-
ing disinhibition, thereby increasing the apparent affinity of 
SERCA for Cain (Colyer, 1998; Wray and Burdyga, 2010). These 
modulations are simplified in the model, in which direct phos-
phorylation of SERCA by these kinases increases the affinity for 
Cain (Seq. G24). Two Ca are transported and approximately two 
protons are counter-transported per ATP hydrolyzed (Tran et al., 
2009) (Seqs. G25–G29). Because the SR Vm and the proton con-
centration gradient are both assumed zero, the energy cost of 
transport is the result of the Ca concentration gradient alone. 
The time courses of the phosphorylated forms are governed by 
Seqs. J60 and J61.
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To compare the simulated Vm and Cain with the experi-
mentally determined Vexp and Caexp (Knot and Nelson, 
1998), I took as the responses to pressure the means 
<Vm> and <Cain> over the last 50 s of the 300-s simula-
tion. The means changed little over this last 50 s. A set 
of parameters that gave a close fit (see Materials and 
methods) of <Vm> and <Cain> to Vexp and Caexp (Fig. 2) 
was designated the normal set (Table S6). The root 
mean square (rms)-relative differences over the six ex-
perimentally tested intravascular pressures were 1.25% 
for Vm and 3.21% for Cain. Variations of most of the pa-
rameters by ±10% had little effect on the rms errors of 
the fits (see Robustness below).
Means were also calculated for all other variables and 
for all fluxes or currents. For each trial run, automatic 
plots of the means as functions of intravascular pressure 
Many of the parameters, excluding the few well-established ones, 
were adjusted to achieve a close simulation of the primary experi-
mental targets, Vm and Cain, as functions of intravascular pressure 
(Knot and Nelson, 1998). Because the number of adjustable pa-
rameters relevant just to the fit of the Knot and Nelson data was 
very large (189), it was impractical to search for the best fit over all 
parameters simultaneously. Instead, the fit was selective and itera-
tive. The parameters of the components with the largest impacts 
(identified below) were adjusted one at a time, first to improve the 
global fit while maintaining realistic local properties. The fit was 
quantified separately for Vm and for Cain by calculating, first, the 
difference between the simulated value and experimental value for 
each of six pressures; second, each difference divided by the ex-
perimental value to get the relative difference; and, finally, the 
square root of the mean of the squares of the relative differences 
(rmsRelErr). The primary goal was to minimize rmsRelErr_Cain. 
With a few exceptions, the parameter values were determined to 
only one or two significant places. This was justified by the shallow-
ness of the minimum (see Robustness below). A parameter set, 
called the “normal” parameter set (Table S6), minimized rmsRel-
Err_Cain and, within a small margin, rmsRelErr_Vm as well.
The sensitivity of the fit to changes in 24 global parameters was 
quantified as rmsRelErr_Vm and rmsRelErr_Cain after changing 
each parameter, one at a time, to 0.8, 0.9, 1.1, and 1.2 times their 
normal values. These were in all cases compared with the rmsRel-
Errs after elimination of the component. In addition, the sensi-
tivities of the simulations of Vm and Cain and the output of the 
individual components to changes in 97 local parameters were 
calculated based on the differences between perturbed simulated 
values and normal simulated values (for details see legends of 
Figs. S8–S10).
Online supplemental material
Model equations (Mathcad program) are available in a PDF file. 
A PDF file of reaction schemes for -adrenergic signaling, -
adrenergic signaling, NaKCl cotransporter, NCX exchanger, and 
P2XR is also available. Figs. S1–S10 and Tables S1–S6 are part of 
the online supplemental material. Figs. S1–S5 show the time 
courses of 15 variables, each at 20, 60, and 100 mm Hg. Figs. S6 and 
S7 show the sensitivities to variations in the global parameters of 
the fit of simulated <Vm> to Vexp and of simulated <Cain> to Caexp. 
Figs. S8–S10 show the sensitivities of <Vm>, <Cain>, and the outputs 
of individual components to variations in 97 global and local pa-
rameters. Table S1 shows the set of parameters determining the 
application of intravascular pressure and concentrations of chemi-
cal effectors. Table S2 shows the values of selected variables from a 
run with the normal set of parameters. Table S3 shows the effects of 
varying and/or holding constant key variables and parameters on 
the output oscillations. Table S4 shows the fractional changes in 
<Vm>, <Cain>, and the local component output per millivolt change 
in additive parameters that set the midpoints of voltage depen-
dence. Table S5 shows the dose–response parameters characteriz-
ing the simulated responses to chemical effectors. Table S6 gives 
the values of the normal set of parameters and their derivations. 
The online supplemental material is available at http://www.jgp 
.org/cgi/content/full/jgp.201511380/DC1.
R E S U L T S
Simulations of Vm and Cain as functions 
of intravascular pressure
Simulations were run for 300 s, with pressure applied 
gradually starting at 10 s, reaching a steady value by 15 s, 
and sustained to 300 s. With most sets of parameter values 
tested, the simulated variables oscillated (Figs. S1–S5). 
Figure 2. Simulated and experimental Vm and sarcoplasmic Ca 
concentration as functions of intramural pressure. (A) Vexp 
(red squares) are the means over 30 s of the observed Vms after 
steady-state responses to the indicated intramural pressures were 
reached, recorded in rat cerebral arteries (Knot and Nelson, 
1998). <Vm> (black circles) are the means of Vm over the last 50 s 
of a 300-s simulation with the normal parameter set (Table S6). 
In the simulations, the indicated intramural pressures were ap-
plied starting at 10 s. (B) Caexp (red squares) are the mean Ca 
concentrations recorded under the conditions in A, and <Cain> 
(black circles) are the means of Cain calculated as in A. Error bars 
represent standard deviations of the experimental data.
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of the number of BK channels (BKT) to between 1 and 
10% of the normal value simulated the effects of 100 nM 
iberiotoxin on Vexp and Caexp at 60 mm Hg (Fig. 3, 
A and B). In the model, reducing the number of RyR 
channels (RyRT) to 50% of the normal value and reduc-
ing it to 1% had nearly the same effect on <Vm>, and both 
overlap with Vexp at 60 mm Hg in the presence of 10 µM 
ryanodine (Fig. 4 A). (There may be three distinct ryano-
dine-binding sites on RyR2, binding to each of which pro-
motes a distinct state of the channel [Bidasee et al., 2003]. 
At 10 µM ryanodine, however, the “shut” state predomi-
nates.) The mean effect of ryanodine on Caexp was simu-
lated by the reduction of RyRT to between 80 and 50% of 
the normal value, but 1% of the normal value gave <Cain> 
within the experimental error in Caexp (Fig. 4 B). Finally, 
reduction of CaVT to 1% of the normal value simulated 
the small effect of 10 nM nisoldipine on Vm at 80 mm Hg 
but not at 40 mm Hg, where the reduction of CaVT gen-
erated a hyperpolarization not observed experimentally 
(Fig. 5 A). Reduction of CaVT to 1% or to 0.1% of its 
provided insight into the effects of changing parameter 
values. The means of the salient variables and currents 
from a run with the normal parameters, in the absence 
of all effectors except intravascular pressure, are shown 
in Table S2. In many cases, for example Cajun and IBK_ALL, 
the means are much smaller than the peak values 
(Figs. S4 H, inset, and S5 E, inset; the peaks are sharper 
in the insets than in the main panel because the plot-
ting density is greater). In the absence of chemical effec-
tors, the concentrations of second messengers and the 
activities of phosphodiesterases and kinases remain at 
their basal levels. Even in the absence of chemical effec-
tors, however, PKC activity changes with Cain.
Simulations of the effects of inhibiting BK, RyR,  
and CaV channels
Knot et al. (1998) determined the effects on Vexp and 
Caexp of the inhibition of three key components: BK chan-
nels by iberiotoxin, RyR channels by ryanodine, and 
CaV channels by nisoldipine. In the model, reduction 
Figure 3. Simulation of the effects of inhibiting BK. (A) Vexp and 
(B) Caexp (red circles with error bars) were recorded at 60 mm Hg 
in the presence of 100 nM iberiotoxin (Knot et al., 1998). Vm and 
Cain were simulated with the number of BK molecules (BKT) set 
at the indicated multiples (1–120%) of its normal value. <Vm> and 
<Cain> are the means over the last 50 s of a 300-s simulation (black 
symbols). Except for BKT, the parameters were normal. Error bars 
represent standard deviations of the experimental data.
Figure 4. Simulation of the effects of inhibiting RyR. (A) Vexp and 
(B) Caexp (red circles with error bars) were recorded at 60 mm 
Hg in the presence of 10 µM ryanodine (Knot et al., 1998). Vm 
and Cain were simulated with RyRT set at the indicated multiples 
(1–120%) of its normal value. <Vm> and <Cain> are the means 
over the last 50 s of a 300-s simulation (black symbols). Except for 
RyRT, the parameters were normal. Error bars represent standard 
deviations of the experimental data.
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and replenishes CaSRper, and CaSRper both sensitizes RyR 
and feeds Cajun (Fig. 1).
Oscillations
Vm, Cain, and other of the simulated variables showed 
sustained, synchronous oscillations (Figs. S1–S5). Such 
synchronous oscillations, however, are not seen experi-
mentally. Rather, there are sporadic, localized spikes 
in Ca (“sparks”) and, imperfectly correlated with them, 
spontaneous, transient outward currents (“STOCs”) 
(Nelson et al., 1995; Lifshitz et al., 2011). Sparks and 
STOCs result from the activation of RyR and BK chan-
nels, respectively. Sparks and the correlated STOCs 
occur at individual junctions and are stochastic. Their 
properties depend on the gating kinetics and spatial 
distributions of RyR and BK channels (Lifshitz et al., 
2011), on the diffusion of Ca, and on the electrotonic 
spread of changes in Vm. In the model, however, all in-
dividual channels of a type were simultaneously in the 
same state determined by the steady-state equation for 
Popen. There were no delays in the transitions between 
steady states. Nonetheless, the underlying mechanism 
driving the irregular spikes of experimentally observed 
sparks and STOCs and of the regular oscillations in the 
simulation are likely the same.
The mechanism as it applies to RyR and sparks is anal-
ogous to the flushing of a toilet. The flapper stays up 
(i.e., RyR continues to open) until the tank (SRper) nearly 
empties (but see Sobie et al., 2002). This toilet analogy 
needs the refinement that the filling of the tank beyond 
a certain level promotes the opening of the flapper 
(RyR), and the filling of the bowl (junctional domain) 
keeps the flapper up (RyR open). The spikes in Cajun 
drive the spikes in IBK, i.e., the STOCs (Hill-Eubanks et al., 
2011). Although this mechanism for sparks and STOCs 
is too simple, because not all sparks result in STOCs, 
and not all STOCs are correlated with sparks (Lifshitz 
et al., 2011), it should suffice for the correlated sparks 
and STOCs.
The mechanisms promoting and sustaining the oscil-
lations in the model are illuminated by the effects of 
changes in component parameters on the frequency of 
oscillations (Table S3). In the model with the normal 
set of parameters, all variables oscillated synchronously, 
albeit with widely different amplitudes (Figs. S1–S5). 
During the interval from 150 to 155 s (for illustration) 
and at an intravascular pressure of 60 mm Hg, the com-
mon frequency was 2.9 Hz. The rate of refilling of SRper 
depended on the rate of SERCA pumping Ca into the 
SRcen: the frequency decreased to 2.2 Hz when ISERCA_
MAX was set at 80% of its normal value and increased to 
3.3 Hz when ISERCA_MAX was set at 120% of its normal 
value. It has been observed that inhibition of SERCA 
decreases the frequency of sparks (Vandier et al., 1998).
The refilling also depended directly on the Ca gradient 
between SRcen and SRper. Although normally CaSRcen 
normal value simulated, at least qualitatively, the effect of 
nisoldipine on Caexp; namely, the increase in Cain with 
pressure is completely abrogated over the entire pressure 
range (Fig. 5 B).
Ca concentrations in different compartments
The Ca concentrations in the five compartments in-
cluded in the model spanned three orders of magni-
tude. For example, during the interval from 250 to 300 s 
at 60 mm Hg, the mean concentrations (µM) are 0.195 
<Cain>, 108 <CaSRcen>, 82.3 <CaSRper>, 0.7 <Cajun>, and 
0.53 <CaNSCstr>, and the peak values in the smaller com-
partments (microdomains), namely of CaSRper, Cajun, 
and CaNSCstr, were considerably higher than their means. 
These concentrations were in the ranges of activation of 
compartment-specific targets or functions; e.g., Cain ac-
tivates myosin light chain kinase, CaNSCstr activates ClA, 
Cajun activates RyR and BK, CaSRcen is a reservoir for IP3R 
Figure 5. Simulation of the effects of inhibiting CaV channels. 
(A) Vexp and (B) Caexp (red circles with error bars) were recorded 
at various intravascular pressures in the presence of 10 nM ni-
soldipine (Knot and Nelson, 1998). Vm and Cain were simulated 
with CaVT set at the indicated multiples (1–120%) of its normal 
value. <Vm> and <Cain> are the means over the last 50 s of a 300-s 
simulation (black symbols). Except for CaVT, the parameters were 
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Robustness
Robustness is the insensitivity of the output of a mecha-
nism to changes in its components. The mathematical 
model of a mechanism is robust to the extent that its 
output is insensitive to changes in the parameters of its 
governing equations. As in the well-known case of bacte-
rial chemotaxis, in which adaptation was insensitive to 
parameter changes but tumbling rate was not (Alon 
et al., 1999), a mechanism and a model can have both 
robust and sensitive outputs. Also, of course, a model is 
likely to be more sensitive to changes in some parame-
ters than in others.
Sensitivity was examined in two ways. In the first, the 
effects of changes in parameters on the rms-relative dif-
ferences between Vexp and <Vm> (Fig. S6) and between 
Caexp and <Cain> (Fig. S7) were determined at six intra-
mural pressures (Materials and methods). The param-
eters changed were the numbers of functional molecules 
of each component. These numbers represent the ex-
pression levels, which are likely to vary among cells. The 
parameters were changed, one at a time, to 0.8, 0.9, 1.1, 
and 1.2 times their normal values. In addition, they 
were set to zero. The model lacks redundancy, so that 
insensitivity of the simulations to 10 and 20% changes 
in expression levels is pertinent to robustness only if 
complete removal of the component has a significant 
effect on the fit.
The perturbed rms-relative errors are also compared 
with the normal rms-relative errors, rmsRelErr_Vm and 
rmsRelErr_Cain, which were 1.25 and 3.21%, respectively, 
and indicated by dashed red lines in Figs. S6 and S7. Also 
shown as reference lines for a moderately perturbed 
state are the rms-relative errors simulated with the param-
eters for the channel composed of BK channel  sub-
units alone, i.e., in the absence of 1 subunits (Bao and 
Cox, 2005). These are 16.7 and 21.0%, respectively.
The rms-relative errors were obtained for perturbed 
expression levels of 24 components. The model has 37 
protein components, but some are not active in these 
simulations because chemical effectors are absent, and 
some are enzymes assumed to be in 1:1 complexes with 
their targets and, hence, with no separate parameter for 
expression. The rms-relative errors were insensitive to 
the total elimination of AC, KATP, and sGC because, in 
the absence of chemical effectors, these components 
were active only at a basal level. There were 14 compo-
nents, of which the elimination of any one resulted in 
an rms-relative error in either Vm or Cain >10%. For 
eight of these (BK, Caleak, ClA, Clleak, IP3R, NaK, NSCne, 
and BUFjun), altering the number per cell by ±20% 
yielded rms-relative errors in Vm and Cain <5%. These 
components play significant roles in the model, and yet 
<Vm> and <Cain> were relatively insensitive to their ex-
pression levels. The simulations of Vexp and Caexp were 
more sensitive to changes in the numbers of CaV, NSCstr, 
PLC, PMCA, RyR, and SERCA; altering the number 
oscillated with a small amplitude (Fig. S4, A–C), this os-
cillation was not required for oscillation in CaSRper and 
Cajun. Fixing CaSRcen at 108 µM, its normal mean value at 
60 mm Hg, yielded a frequency of 3.0 Hz in the other 
variables. Fixing CaSRcen at 97.2 µM, 90% of its normal 
value, eliminated the oscillations. Fixing CaNSCcen at 110% 
of its normal value, 118.8 µM, however, increased the 
frequency to 5.3 Hz, consistent with the more rapid refill-
ing of SRper. At 129.6 µM CaNSCcen, 120% of its normal 
value, there was again no oscillation, and the rate of re-
filling of SRper equaled the rate of its emptying via RyR.
Consistent with the idea that the periodic drop in CaS-
Rper drives the oscillation, fixing CaSRper either at its normal 
mean value (82.3 µM) or at 65.8 µM (80% of normal) or 
at 98.8 µM (120% of normal) eliminated all oscillations. 
It follows that the frequency should increase as the rates 
of emptying and refilling of SRper increases, and these 
will increase as VOLSRper decreases, and vice versa. In the 
simulation, the frequency increased when VOLSRper was 
decreased to 80% of normal, and the frequency decreased 
when VOLSRper was increased to 120% of normal.
The drop in CaSRper and the rise in Cajun depend on 
Ca flux through the open RyR channel, the opening of 
which depends on both of these concentrations. De-
creased numbers of RyR compared with normal re-
sulted in decreased Ca flux and decreased frequency, 
whereas increased numbers of RyR resulted in increased 
frequency. In the model, CaSRper binding promotes RyR 
activity by decreasing the dissociation constant, KRyR_Ca_act, 
from KRyR_Ca_max toward KRyR_Ca_min. With these three pa-
rameters fixed at a low value of 6.0 µM, promoting RyR 
activity, the frequency was 5.4 Hz. At an intermediate 
value of 7.5 µM, the frequency was 2.2 Hz, and at a high 
value of 9.0 µM (low RyR activity), there was no sus-
tained oscillation; rather, a steady state was reached.
The oscillation of Cajun was necessary but not suffi-
cient for all other oscillations. Both RyR and BK chan-
nels are activated by Cajun. Allowing Cajun to oscillate as 
usual but fixing just the input to RyR of Cajun at its nor-
mal mean value, 0.7 µM, or at 80% (0.56 µM) or 120% 
(0.84 µM) of its mean value eliminated all oscillations. 
It follows that there are no other oscillations without 
oscillation in RyR activity. On the other hand, if Cajun 
input to RyR was allowed to vary with time as usual and 
only the input to BK channels was fixed (Table S3, bot-
tom), oscillations in IRyR_ALL, CaSRper, and Cajun contin-
ued, albeit with frequencies changed as expected, but 
there was no oscillation in IBK_ALL, Vm, or in any sarco-
lemmal currents. These last currents are all dependent 
on the electrochemical potential, and some are also car-
ried by voltage-activated channels. RyR oscillations en-
train BK channels, and BK channel oscillations entrain 
Vm. There is also strong negative feedback on BK chan-
nel activity of the hyperpolarization caused by IBK, which 
contributes to the sharpness of the spikes of simulated 
IBK and also of experimentally observed STOCs.
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concentration of extracellular ATP. Also, the addition 
was either steady or pulsatile (Fig. 6 C), with the latter 
simulating release from sympathetic neurovascular junc-
tions (Todorov et al., 1999). The EC50 for the increase in 
<Cain> caused by the steady application of A was 0.41 µM 
(Table S5). The EC50 for norepinephrine-induced 
of any one of them by ±20% yielded an rms-relative 
error in Vm or Cain >5%. Only for PLC, however, did the 
rms-relative errors exceed those obtained in the ab-
sence of BK 1. Sensitivity to variation in PLCT is caused 
by the dependence of NSCstr, NSCne, and PKC on the 
basal level of DAG, the regulation of which in the model 
is highly simplified. Overall, the rms-relative errors in 
the simulations were moderately insensitive to changes 
in the expression levels of most of the components.
In a second approach, I looked at the sensitivity of the 
simulations to changes by ±10% of 97 parameters, includ-
ing the expression levels and the kinetic parameters of 
the components (Figs. S8–S10). I calculated global sen-
sitivities as the absolute values of the relative changes 
|(<Vm>norm  <Vm>perturbed)/<Vm>norm| and |(<Cain>norm 
 <Cain>perturbed)/<Cain>norm|, where  is 0.1, the frac-
tional change in the parameter, and averaged these 
over six intramural pressures. In addition, I calculated 
the fractional change in the output of the cognate com-
ponent (e.g., IBK for BK channel parameters, ICaV for 
CaV channel parameters, etc.) per fractional change in 
each parameter. These were the local sensitivities. Calcu-
lated this way, sensitivity approximates the mean of the 
absolute value of the partial derivative [ln(Z)]/[ln
(parameter)], where Z is <Vm>, <Cain>, or the mean out-
put of the cognate component. A sensitivity of 1 indicates, 
for example, that a 10% change in a given parameter 
results in a 10% change in output.
For most of the 97 parameters considered, the global 
sensitivities are far <1 and also less than the sensitivities of 
the cognate components (Figs. S8–S10). For <Vm> and 
<Cain>, the sensitivities are ≤0.1 for 54 and 53 parameters, 
respectively, whereas the component sensitivities are ≥0.4 
for 65 parameters. Five additional parameters, Vx (where 
x is the relevant component), appear as the expression 
(Vm  Vx) in exponentials. These were perturbed by 
±2 mV, and a modified sensitivity was calculated 
(Table S4). Except for the sensitivity of <Cain> to VCaV_act, 
the sensitivities of <Vm> and <Cain> were far less than the 
component sensitivities. Thus, at least in the vicinity of 
the normal set, the effects of most parameter changes on 
<Vm> and <Cain> are small both absolutely and relatively 
compared with their effects on the outputs of their cog-
nate components. The model is buffered against changes 
in many of its parameters and can be considered robust.
Chemical effectors
-adrenergic input.
The effects on <Vm> and <Cain> of an -adrenergic ago-
nist (A) were simulated at 60–mm Hg intravascular 
pressure and normal parameters (Fig. 6, A and B). The 
association and dissociation rate constants of A were 
selected so that its equilibrium dissociation constant was 
10 µM, characteristic of norepinephrine (see Table S6). 
A was added alone or simultaneously with the same 
Figure 6. Effects of -adreneric agonist (A) and ATP on <Vm> 
and <Cain> at 60 mm Hg. (A) <Vm> and (B) <Cain> are the means 
over the last 50 s of a 300-s simulation computed with normal pa-
rameters. A alone (red symbols) or A and ATP together at the 
same concentration (black symbols) were added either steadily 
from t = 40–300 s (C; dashed line) or in pulses from t = 100–300 s 
(C; solid line). Pulses were on for 1 s and were off for 1.5 s 
(0.4 Hz), 4 s (0.2 Hz), or 9 s (0.1 Hz). The rate constant for both 
the rise and fall of a pulse was 2/s. (C) Nominally 1-µM pulses at 
0.2 Hz and (inset) two cycles on expanded scale (solid line) are 
shown, at a steady application of 1 µM (dashed line).
 o
n






Published June 29, 2015
90 Model of arterial smooth muscle myogenic response
promote BK channel activity, among other channels 
that are modulated (Fig. 1). The effects of their steady 
application on <Vm> and <Cain> were simulated at 60–mm 
Hg intravascular pressure and normal parameters (Fig. 7, 
A and B). For A, the EC50s for the two variables 
(Table S5) were similar to the EC50s for epinephrine 
determined in rat mesenteric arteries in the presence 
of the AR blocker prazocin at 60 mm Hg, namely, 
0.79 µM for hyperpolarization and 0.25 µM for relax-
ation (Garland et al., 2011). In the model, elimination 
of KATP suppressed the A-induced hyperpolarization, 
simulating the observed effect of the KATP inhibitor 
glibenclamide (Garland et al., 2011). In the model, how-
ever, elimination of KATP suppressed the A-induced 
decrease in <Cain>, counter to the observed lack of 
effect of glibenclamide on relaxation (Garland et al., 
2011). The model lacks additional significant pathways 
for the lowering of tension by PKA.
For EET, the EC50s for <Vm> and <Cain> from the 
simu lation were 0.54 and 0.24 µM (Table S5). The EC50 
for 11,12-EET–induced vasodilation of pressurized mes-
enteric arteries, however, was far lower, in the range of 
1 to 10 nM (Earley et al., 2005). For NO, the EC50s for 
<Vm> and <Cain> were 0.46 and 0.40 µM (Table S5). The 
observed EC50s for relaxation were higher, 8 µM 
for aorta and 5 µM for femoral artery (Nimmegeers 
et al., 2007). Roles for sGC-independent NO effects 
(Nimmegeers et al., 2007; Yuill et al., 2010) were not 
considered in the model.
Mitigating the effects of the loss of BK 1
In mice, knockout of BK 1 subunit reduces the Ca sen-
sitivity and shifts the G-V curve of the BK channel to the 
right so that STOCs are less efficiently activated by Ca 
sparks (Brenner et al., 2000; Bao and Cox, 2005). Low 
expression of BK 1 results in increased arterial SM 
tone and increased blood pressure (Brenner et al., 2000), 
although the latter effect depends on the mouse strain 
(Sachse et al., 2014). In the simulation with BK channel 
parameters appropriate for channels composed of 
 alone (Horrigan and Aldrich, 2002), <Vm> and <Cain> 
are higher at all pressures than <Vm> and <Cain> simu-
lated with the normal parameters, which include those 
for BK  in complex with 1 (Bao and Cox, 2005) (Fig. 8). 
SM tension is directly related to <Cain>, and thus the 
myogenic response is predicted to be abnormal in the 
absence of 1.
A, EET, and NO all brought <Vm> and <Cain> closer 
to their normal values and hence should have a normal-
izing effect on the myogenic response. At least in the 
simulation, one vasorelaxant is more effective than the 
others (Fig. 8). For effector concentrations approxi-
mately optimal for shifting the BK 1 knockout curves 
toward the normal curve, the mean over six intramural 
pressures of |(<Cain>  <Cain,norm>)/<Cain,norm>| for the 
1 knockout with no effector was 19.3%, with 0.1 µM 
contraction of isolated rat mesenteric arteries pressur-
ized to 60 mm Hg was 0.25 µM (Enouri et al., 2011). 
The EC50 for the effects of the steady application of A 
plus ATP was lower than that for A alone, more so for 
the effects on <Cain> than on <Vm> (Table S5). The maxi-
mum depolarizations and maximum increases in Cain, 
however, were nearly identical for A alone and A plus 
ATP. Thus, ATP enhanced the effects of A more at 
lower than at higher concentrations. With pulsatile ap-
plication, the EC50s for the effects of A plus ATP were 
also lower than the EC50s for the effects of A alone.
Pulsatile application was both effective and economi-
cal. For example, 80 1-s pulses over 200 s (i.e., at 0.4 Hz) 
of nominally 3.2 µM A plus ATP increased <Cain> by 
89 µM, whereas steady application of 3.2 µM A plus ATP 
increased <Cain> by 97 µM. The quantity of A added in 
pulses, however, was cumulatively only 15% of that added 
during steady application. Note that the effector concen-
tration in a pulse reached only 75% of the nominal con-
centration after 1 s, when the pulse turned off (Fig. 6 C).
A, EET, and NO input. These three effectors hyperpolar-
ize Vm and lower Cain by overlapping pathways. They all 
Figure 7. Effects of -adrenergic agonist (A), EET, and NO on 
<Vm> and <Cain> at 60 mm Hg. (A) <Vm> and (B) <Cain> were 
computed as before with normal parameters. Effectors were 
added steadily from t = 40–300 s.
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over the relevant ranges of inputs and time. These crite-
ria concern the testability and conformity of the model 
to properties of arterial SM inferred from experiments. 
If the model satisfies these criteria, it consolidates and 
tests the consistency of these inferences. Where the 
model fills in or goes beyond previously proposed mech-
anisms, it predicts that these mechanisms will be veri-
fied experimentally.
A set of parameters (the “normal” set) was obtained 
that resulted in a close fit of the model-generated Vm and 
Cain to the experimentally determined Vexp and Caexp as 
functions of intravascular pressure (Knot and Nelson, 
1998) (Fig. 2). With the same normal parameters, except 
that the number of molecules of the target component 
was progressively decreased, the model also simulated, at 
least qualitatively, the experimentally determined effects 
of inhibiting, one at a time, RyR, BK, and CaV channels 
(Knot et al., 1998) (Figs. 3–5). This conformity of the 
model to experimental data beyond those used to derive 
the normal parameters is, at the very least, the absence of 
its invalidation; i.e., the model is possibly a valid mathe-
matical representation. Nevertheless, the normal set of 
parameter values cannot be considered well determined 
or providing a unique fit to the limited experimental 
data available. Even if there were more data, unique best-
fit parameter values for the complex of mechanisms con-
stituting the model would be elusive (Hines et al., 2014). 
The existence of even one set of normal parameters, 
however, confirms that the combination of reasonably 
behaving components as in the model can result in 
global behavior that simulates experimentally observed 
behavior. Again, the model is possibly a valid representa-
tion of arterial SM cell function in the limited range of 
the myogenic response.
The activities of all channels, transporters, kinases, 
phosphatases, and phosphodiesterases are represented 
by steady-state equations (not explicitly dependent on 
time). These include all of the components involved in 
the control of Vm and Cain by pressure in the absence of 
other effectors. The steady-state equations are called by 
the differential equations that determine as functions of 
time Vm and all ion concentrations, among other vari-
ables. In this approach, the faster processes are governed 
by steady-state equations, and the slower processes are 
governed by differential equations (Saucerman and 
McCulloch, 2004). For most components, the steady-state 
equations differ from those used in previously published 
models of SM. Here, all fluxes and currents through 
channels are driven by the Goldman–Hodgkin–Katz con-
stant-field integral of the Nernst–Planck equation, which 
is at least a thermodynamically consistent simplification. 
Primary transporters are driven by the negative free en-
ergy change per mole of the overall reaction, including 
hydrolysis of ATP (µATP). Cotransporters, NCX and 
NaKCl, are modeled with thermodynamically valid reac-
tion schemes and parameters. The model here for NCX, 
A it was 15.1%, with 0.2 µM EET it was 6.4%, and with 
0.4 µM NO it was 3.7%. Among these vasorelaxants, NO 
is the most effective in restoring global Ca concentra-
tions to near-normal over the tested range of intramu-
ral pressure.
D I S C U S S I ON
The model should be evaluated based on whether it 
simulates experimental data, whether it does so with 
credible mechanisms and parameters, whether it incor-
porates all components known to be significant in the 
short-term control of Vm and Cain in arterial SM cells 
(and excludes components not present in these cells), 
and whether the architecture of an arterial SM cell and 
the distribution of components in this architecture are 
adequately represented. Obviously, the equations should 
represent the model adequately and should be solvable 
Figure 8. Effects of intravascular pressure and vasorelaxants on 
<Vm> and <Cain> in the absence of BK 1. (A) <Vm> and (B) <Cain> 
were computed as before either with normal parameters (closed 
red circles), which include those appropriate for the BK chan-
nel containing both  and 1 subunits (+BK1) (Bao and Cox, 
2005), or with parameters appropriate for BK  alone (BK1) 
(Horrigan and Aldrich, 2002), in the absence (open red circles) 
or presence (open black symbols) of effectors. 0.1 µM A (open 
black triangles), 0.4 µM NO (open black squares), or 0.2 µM EET 
(open black diamonds) was added steadily from t = 40–300 s.
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release this Ca signal into a restricted volume, a micro-
domain, also containing the ClA channels.
A simplification of the model is that each channel and 
transporter is found only in the membrane bounding 
one compartment; e.g., RyR is exclusively in the periph-
eral SR membrane bounding the junctional microdo-
main, and IP3R is exclusively in the central SR membrane 
(c.f. Kapela et al., 2008). In arterial SM, however, RyR is 
also found in the central SR, and IP3R is likely also in the 
peripheral SR membrane (Adebiyi et al., 2010). More-
over, not all BK channels are directly apposed to RyR 
(Lifshitz et al., 2011). Would the output of the model dif-
fer significantly if it included more realistic distributions 
of components? BK channels outside the junctions ex-
posed to global Cain would have very low open probabili-
ties. Active RyR channels in the central SR would raise 
Cain, opposing the lowering of Cain by junctional RyR act-
ing through BK and CaV channels. Given that inhibiting 
RyR with 10 µM ryanodine raised Cain (Fig. 4), RyR must 
be active predominantly in junctions in arterial SM.
In the model, NCX is in the sarcolemma facing the 
sarcoplasm. Given the simulated values of Nain, Cain, 
and Vm, NCX transports Na inward and Ca outward. 
NCX makes small contributions to the control of Vm 
and Cain (Table S2 and Figs. S6 and S7). There is, how-
ever, evidence that NCX makes a significant contribu-
tion to the maintenance of arterial SM tone (Zhang, 
2013). To do so, NCX would need to run in reverse 
mode, transporting Na outward and Ca inward. In the 
range of Vm in the SM cell and if Cain were 0.2–1 µM, 
Nain would need to be >16–25 mM to drive influx of Ca. 
More relevant to the control of Cain by pressure is the 
possibility that NCX is present in the stretch-transduc-
ing microdomains, amplifying the activation of NSCstr 
channels and the resulting influx of Na by increasing 
CaNSCstr. In that case, CaNSCstr would be 0.5 µM, and 
NaNSCstr would need to be >20 mM to get influx of Ca via 
NCX. I have simulated the addition of NCX to the NSCstr 
microdomain and found that with reasonable rates 
of diffusive equilibration of NaNSCstr with Nain and plau-
sible VOLNSCstr, the INSCstr needed to obtain NaNSCstr of 
>20 mM would in itself depolarize Vm to approximately 
30 mV and raise Cain to 300 nM without much 
contribution from NCX. A major role of NCX in the 
short-term myogenic response seems unlikely. There is, 
however, evidence that NCX runs in reverse mode in a 
microdomain shared with NSCne (Zhang, 2013), which 
I have not explored in the current model.
The model incorporates only pared-down versions of 
signaling via - and -adrenergic receptors and G pro-
teins. Cyclic nucleotide–independent effects via G, 
which can promote vasoconstriction (Zhou et al., 2008) 
or vasorelaxation (Meens et al., 2012), depending on 
the terminal components of the circuits, are neglected. 
Including G effects would require a fine-grained ap-
proach beyond the scope of the present model.
in particular, is more complicated than that in Kapela et 
al. (2008) and less complicated than that in Kang and 
Hilgemann (2004). The equations for the open probabil-
ity of BK channels are taken from Horrigan and Aldrich 
(2002), and those for CaV channels are from Rubart 
et al. (1996). For other channels, the local mechanisms 
incorporated the reported qualitative effects of Vm, Ca, 
and DAG on open probabilities. Similarly, for all modu-
lated channels and transporters, the reported qualitative 
effects of phosphorylation were represented quantita-
tively. The data did not exist to train these local models 
and to obtain local best-fit parameters. At most, a partial 
set of related parameters was available (Table S6). For 
rate constants unconstrained by experiment, I used val-
ues within the range of biochemical reaction rate con-
stants and also consistent with the reactions reaching a 
steady state within 200 s.
The disparate signaling roles of Ca require separate 
microdomains (see Introduction). The model contains 
two types: the junctional microdomains and the stretch-
transducing microdomains. Junctions between the 
peripheral SR and the sarcolemma were identified in 
electron micrographs of urinary bladder SM, where 
they contain RyR and CaV channels and promote con-
traction (Moore et al., 2004). In the model, I have as-
sumed that similar subcellular structures exist in arterial 
SM but that their role is to promote relaxation. There is 
close apposition of the peripheral SR and caveolae in 
arterial SM (Shaw et al., 2006). One role suggested for 
such structures is the direct coupling, independent of 
Ca release, of IP3R and TRPC3 (Adebiyi et al., 2010). 
Thus, physically restricted spaces that could serve as mi-
crodomains for Ca exist in arterial SM. Furthermore, at 
least in airway myocytes, arrays of RyR in SR and arrays 
of BK channels in the sarcolemma are close, although 
not overlapping (Lifshitz et al., 2011).
There is no evidence for stretch-transducing microdo-
mains formed by apposing membranes, but this arrange-
ment is not required for a Ca microdomain. NSCstr and 
ClA channels are in the same membrane, with 1 NSCstr 
channel per approximately 10 ClA channels according 
to the fitted normal set of parameters. If the ClA chan-
nels were arrayed in close proximity to the NSCstr chan-
nel, the local Ca concentration could be transiently 
elevated enough (Rizzuto and Pozzan, 2006) to activate 
the ClA channel sufficiently to depolarize Vm. If instead 
ClA channels were sensing Ca delivered directly into 
the global sarcoplasmic pool, the Ca concentration 
needed to activate ClA channels sufficiently would also 
strongly activate myosin light chain kinase and cause 
maximum contraction. Furthermore, experimentally, the 
Ca current via NSCstr channels does not contribute sig-
nificantly to Cain, which is almost entirely caused by influx 
via CaV channels, as seen in Fig. 5 B. Thus, if Ca influx 
via NSCstr channels need be limited and yet achieve 
concentrations greater than Cain, NSCstr channels must 
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The model makes two types of predictions. The first 
type is explicit, and such predictions can be tested by 
straightforward experiments. For example, the model 
predicts the sensitivities of Vm and Cain as functions of 
pressure to partial block of components (Figs. S6 and 
S7). These predictions can be tested by measurements 
of Vexp and Caexp in pressurized arteries over a range of 
concentrations of specific inhibitors, combined with as-
says for the residual activities of the target components. 
It also predicts that observables, such as Vexp and Caexp, 
will be buffered against modest changes in the proper-
ties of components (Figs. S8–S10); i.e., like the model, 
SM cell responses to perturbations are predicted to be 
robust. It predicts the effects of changes in the activities 
and properties of SERCA, RyR, and BK channels on the 
frequency of sparks and STOCs. It predicts the effects of 
the knockout of the BK 1 subunit (Brenner et al., 2000; 
Dong et al., 2008; Sachse et al., 2014) on the myogenic 
response as reflected in Vm and Cain and the effects of 
selected vasoactive agents on the myogenic response 
after knockout of BK 1. Among these vasoactive agents, 
it predicts that NO will be most effective in restoring the 
normal functional relationship between Cain and pres-
sure over its entire range.
The second type of prediction is implicit in the postu-
lated mechanisms included in the model. Two of these 
are the pressure-transducing microdomains contain-
ing NSCstr and ClA channels and the core mechanism 
of spiking Ca concentrations (sparks) and spiking Vm 
(STOCs). These predictions are just a short step beyond 
what others have observed and inferred, made concrete 
by their mathematical expression.
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Figure S1. Simulation of time courses of Vm (A–C), Cain (D–F), and CaNSCstr (G–I) with normal parameters from t = 0–300 s. Insets show 
time courses from t = 150–155 s. Intravascular pressure is 20 mm Hg (A, D, and G), 60 mm Hg (B, E, and H), and 100 mm Hg (C, F, and 
I).
S2 Model of arterial smooth muscle myogenic response
Figure S2. Simulation of time courses of INSCstr_ALL (A–C), IClA (D–F), and ICaV_ALL (G–I) with normal parameters from t = 0–300 s. Insets 
show time courses from t = 150–155 s. Intravascular pressure is 20 mm Hg (A, D, and G), 60 mm Hg (B, E, and H), and 100 mm Hg (C, 
F, and I).
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Figure S3. Simulation of time courses of IPMCA (A–C), INaK (D–F), and ISERCA_ALL (G–I) with normal parameters from t = 0–300 s. Insets 
show time courses from t = 150–155 s. Intravascular pressure is 20 mm Hg (A, D, and G), 60 mm Hg (B, E, and H), and 100 mm Hg (C, 
F, and I).
S4 Model of arterial smooth muscle myogenic response
Figure S4. Simulation of time courses of CaSRcen (A–C), CaSRper (D–F), and Cajun (G–I) with normal parameters from t = 0–300 s. Insets 
show time courses from t = 150–155 s. Intravascular pressure is 20 mm Hg (A, D, and G), 60 mm Hg (B, E, and H), and 100 mm Hg (C, 
F, and I).
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Figure S5. Simulation of time courses of IRyR_ALL (A–C), IBK_ALL (D–F), and IKv (G–I) with normal parameters from t = 0–300 s. Insets 
show time courses from t = 150–155 s. Intravascular pressure is 20 mm Hg (A, D, and G), 60 mm Hg (B, E, and H), and 100 mm Hg (C, 
F, and I).
S6 Model of arterial smooth muscle myogenic response
Figure S6. Sensitivity of the fit of <Vm> to Vexp on variation in the number of molecules of each component. The total number of mol-
ecules or the maximum current of each component of relevance in the absence of chemical effectors was changed one at a time by a 
factor of 0 (or 0.001 in some cases to avoid dividing by zero), 0.8, 0.9, 1.1, and 1.2 times their normal values. (Most enzymes were ex-
cluded because they are assumed to be in 1:1 complexes with their targets.) At each of six intravascular pressures (as in Fig. 2), (<Vm>  
Vexp)/Vexp was calculated; these relative differences were squared, the six values were averaged, and the square root was taken to obtain 
the rms-relative error in <Vm>. With the normal parameters, this was 1.25% (dashed red line). The rms-relative error in <Vm> simulated 
with the parameters relevant to BK channel function in the absence of its 1 subunit (see Fig. 8) is 16.7% (black dashed line). Abbrevia-
tions are defined in Table S6.
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Figure S7. Sensitivity of the fit of of <Cain> to Caexp on variation in the number of molecules of each component. The rms-relative error 
in <Cain> was calculated as in Fig. S6. With the normal parameter set, this was 3.21% (dashed red line). The rms-relative error in <Cain> 
simulated with the parameters relevant to BK channel function in the absence of its 1 subunit (see Fig. 8) is 21.0% (black dashed line).
S8 Model of arterial smooth muscle myogenic response
Figure S8. Sensitivities of <Vm>, <Cain>, and components to parameters. Sensitivity is calculated as the mean over six intramural pres-
sures, and for ±, of |(<Z>  <Znorm>)/<Znorm>|/||, where Z is <Vm>, <Cain>, or the immediate output of the cognate component, e.g., 
<IBK_ALL> for the parameters relevant to BK channel function. The subscript “norm” indicates the value obtained with normal parame-
ters.  is the fractional change in the parameter, which in these cases are ±0.1. Sensitivity so defined is approximately the mean of the 
absolute values of the partial derivative of ln(Z) with respect to ln(parameter) in the vicinity of the normal parameters.
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Figure S9. Sensitivities of <Vm>, <Cain>, and components to parameters. Sensitivity is calculated as the mean over six intramural pres-
sures, and for ±, of |(<Z>  <Znorm>)/<Znorm>|/||, where Z is <Vm>, <Cain>, or the immediate output of the cognate component, e.g., 
<IBK_ALL> for the parameters relevant to BK channel function. The subscript “norm” indicates the value obtained with normal parame-
ters.  is the fractional change in the parameter, which in these cases are ±0.1. Sensitivity so defined is approximately the mean of the 
absolute values of the partial derivative of ln(Z) with respect to ln(parameter) in the vicinity of the normal parameters.
S10 Model of arterial smooth muscle myogenic response
Figure S10. Sensitivities of <Vm>, <Cain>, and components to parameters. Sensitivity is calculated as the mean over six intramural pres-
sures, and for ±, of |(<Z>  <Znorm>)/<Znorm>|/||, where Z is <Vm>, <Cain>, or the immediate output of the cognate component, e.g., 
<IBK_ALL> for the parameters relevant to BK channel function. The subscript “norm” indicates the value obtained with normal parame-
ters.  is the fractional change in the parameter, which in these cases are ±0.1. Sensitivity so defined is approximately the mean of the 
absolute values of the partial derivative of ln(Z) with respect to ln(parameter) in the vicinity of the normal parameters.
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Ta b l e  S 1
Effector application parameters
Parameters Units Values Parameters Units Values
A.0a µM 0 .A1 1/s 2
A.1 µM 0 .A2 1/s 2
.A1 s 4.00E + 01 BP.0 mm Hg 0.00E + 00
.A2 s 5.00E + 01 BP.1 mm Hg 10
.A3 s 3.00E + 02 .BP1 s 1.00E + 01
.A1 1/s 2 .BP2 s 1.50E + 01
.A2 1/s 2 .BP3 s 3.00E + 02
ATP.0 µM 0 .BP1 1/s 2
ATP.1 µM 0 .BP2 1/s 2
.pulse_init s 100 EET.0 µM 0
.pulse_on s 1 EET.1 µM 0
.pulse_off s 9 .EET1 s 4.00E + 01
n.cycles 20 .EET2 s 6.00E + 01
.ATP1 s 4.00E + 01 .EET3 s 3.00E + 02
.ATP2 s 5.00E + 01 .EET1 1/s 2.00E  01
.ATP3 s 3.00E + 02 .EET2 1/s 2.00E + 00
.ATP1 1/s 2 NO.0 µM 0
.ATP2 1/s 2 NO.1 µM 0
A.0 µM 0.00E + 00 .NO1 s 4.00E + 01
A.1 µM 0 .NO2 s 5.00E + 01
.A1 s 4.00E + 01 .NO3 s 3.00E + 02
.A2 s 5.00E + 01 .NO1 1/s 2
.A3 s 3.00E + 02 .NO2 1/s 2
The values shown are for application of intravascular pressure (BP) alone; the concentrations of all other effectors are zero. For each effector, X, two 
concentrations are given, X.0, the initial and base concentration, and X.1, the second concentration. X.0 is applied from t = 0 to t = .X1, when the 
concentration rises (or falls) to X.1 with a rate constant of .X1 until t = .X2. The concentration of X remains constant from .X2 to X3, when it 
begins to fall (or rise) to X.0 with a rate constant of .X2. One or more effectors can be thus added in the same run. In addition, multiple consecutive 
runs with different concentrations of any one of the effectors are initiated with a vector of consecutive concentrations of the effector (see supplementary 
equations, section A). All other effector parameters remain the same for each of these runs. For pulsatile addition of any effector, the first pulse starts at 
t = .pulse_init, and each pulse is on for .pulse_on, off for .pulse_off, and repeated n.cycles times.
aText preceded by a period in the table is subscripted in the program.
S12 Model of arterial smooth muscle myogenic response
Ta b l e  S 2
Means of selected variables from 250 to 300 s in a run with normal parameters
bp mm Hg 10 20 40 60 80 100
Variables Units
V.m mV 6.17E + 01 5.92E + 01 5.18E + 01 4.53E + 01 4.05E + 01 3.73E + 01
Ca.in µM 1.22E  01 1.32E  01 1.63E  01 1.95E  01 2.21E  01 2.38E  01
Ca.NSCstr µM 1.51E  01 2.04E  01 3.60E  01 5.32E  01 6.83E  01 8.12E  01
Ca.jun µM 2.37E  01 3.63E  01 5.11E  01 7.00E  01 8.41E  01 9.17E  01
Ca.SRper µM 1.35E + 02 1.13E + 02 9.99E + 01 8.23E + 01 7.21E + 01 6.72E + 01
Ca.SRcen µM 1.41E + 02 1.24E + 02 1.17E + 02 1.08E + 02 1.03E + 02 1.01E + 02
Cl.in mM 6.19E + 01 6.16E + 01 6.02E + 01 5.65E + 01 5.21E + 01 4.86E + 01
K.in mM 1.49E + 02 1.48E + 02 1.46E + 02 1.41E + 02 1.36E + 02 1.31E + 02
Na.in mM 9.65E + 00 9.69E + 00 9.69E + 00 9.84E + 00 1.01E + 01 1.03E + 01
I.BK_ALLa pA 3.10E  02 1.40E  01 1.09E + 00 2.34E + 00 3.79E + 00 4.67E + 00
I.CaV_ALLa pA 3.33E  01 -4.70E  01 9.45E  01 1.64E + 00 2.36E + 00 2.89E + 00
I.ClA pA 1.23E  01 2.76E  01 1.24E + 00 3.30E + 00 5.52E + 00 7.11E + 00
I.Kv pA 3.80E  02 8.97E  02 3.92E  01 1.13E + 00 2.11E + 00 2.84E + 00
I.NSCstr_ALLb pA 1.35E  02 3.33E  02 9.08E  02 1.55E  01 2.10E  01 2.61E  01
I.NSCne_ALLb pA 2.12E  01 2.27E  01 2.60E  01 2.77E  01 2.79E  01 2.75E  01
I_KATP_ALLa pA 1.96E  01 2.24E  01 3.01E  01 3.65E  01 4.06E  01 4.29E  01
I.Ca_leak pA 1.87E  01 1.80E  01 1.59E  01 1.41E  01 1.28E  01 1.20E  01
I.Cl_leak pA 2.72E  01 2.31E  01 2.48E  01 1.68E  01 1.57E  01 9.06E  02
I.K_leak pA 4.70E  02 2.80E  02 1.14E  01 1.03E  01 1.48E  01 1.19E  01
I.NaK pA 7.21E  01 7.57E  01 8.46E  01 9.79E  01 1.13E + 00 1.27E + 00
I.PMCA pA 1.93E  01 2.54E  01 4.84E  01 8.34E  01 1.20E + 00 1.49E + 00
I.NCX pA 8.56E  02 8.99E  02 9.89E  02 9.38E  02 7.95E  02 6.49E  02
I.NaK_Clc pA 3.33E + 00 3.39E + 00 3.74E + 00 4.54E + 00 5.58E + 00 6.51E + 00
I.IP3R_ALLa pA  3.47E  02 3.28E  02 4.75E  02 5.83E  02 6.77E  02 7.44E  02
I.RyR_jun_ALLa pA 1.79E  02 3.56E  02 5.45E  02 7.80E  02 9.58E  02 1.05E  01
I.SERCA_ALLa pA 2.63E  02 3.50E  02 5.00E  02 6.82E  02 8.16E  02 8.96E  02
PLC_PIP # 4.62E + 02 4.62E + 02 4.62E + 02 4.62E + 02 4.62E + 02 4.62E + 02
IP3 µM 1.70E  01 1.70E  01 1.70E  01 1.70E  01 1.70E  01 1.70E  01
DAG µM 1.70E  01 1.70E  01 1.70E  01 1.70E  01 1.70E  01 1.70E  01
cGMP µM 2.12E  01 2.12E  01 2.12E  01 2.12E  01 2.12E  01 2.12E  01
AC0 # 5.99E + 03 5.99E + 03 5.99E + 03 5.99E + 03 5.99E + 03 5.99E + 03
AC_p # 1.00E + 01 1.00E + 01 1.00E + 01 1.00E + 01 1.00E + 01 1.00E + 01
cAMP µM 2.12E  01 2.12E  01 2.12E  01 2.12E  01 2.12E  01 2.12E  01
PDE_cA µM 9.92E  03 9.92E  03 9.92E  03 9.92E  03 9.92E  03 9.92E  03
PDE_cA_P µM 7.72E  05 7.72E  05 7.72E  05 7.72E  05 7.72E  05 7.72E  05
PDE_cG µM 9.92E  03 9.92E  03 9.92E  03 9.92E  03 9.92E  03 9.92E  03
PDE_cG_P µM 7.72E  05 7.72E  05 7.72E  05 7.72E  05 7.72E  05 7.72E  05
relPKA none 2.80E  03 2.80E  03 2.80E  03 2.80E  03 2.80E  03 2.80E  03
relPKG none 4.99E  03 4.99E  03 4.99E  03 4.99E  03 4.99E  03 4.99E  03
relPKC none 6.86E  02 7.70E  02 1.01E  01 1.24E  01 1.40E  01 1.49E  01
relPKC none 9.11E  02 9.11E  02 9.11E  02 9.11E  02 9.11E  02 9.11E  02
BK # 1.29E + 03 1.29E + 03 1.24E + 03 1.21E + 03 1.20E + 03 1.20E + 03
BK_PKA # 3.61E + 00 3.60E + 00 3.45E + 00 3.39E + 00 3.36E + 00 3.35E + 00
BK_PKC # 1.92E + 02 1.96E + 02 2.48E + 02 2.71E + 02 2.82E + 02 2.87E + 02
BK_PKG # 1.29E + 01 1.29E + 01 1.23E + 01 1.21E + 01 1.20E + 01 1.20E + 01
CaV # 2.78E + 03 2.76E + 03 2.70E + 03 2.65E + 03 2.61E + 03 2.59E + 03
CaV_PKC # 1.91E + 02 2.12E + 02 2.73E + 02 3.27E + 02 3.64E + 02 3.86E + 02
CaV_PKG # 2.78E + 01 2.76E + 01 2.70E + 01 2.64E + 01 2.60E + 01 2.58E + 01
NaKCl # 9.36E + 03 9.29E + 03 9.09E + 03 8.91E + 03 8.78E + 03 8.71E + 03
NaKCl_PKC # 6.38E + 02 7.10E + 02 9.12E + 02 1.09E + 03 1.22E + 03 1.29E + 03
NSCstr # 2.52E + 02 2.49E + 02 2.44E + 02 2.42E + 02 2.42E + 02 2.41E + 02
NSCstr_PKC # 6.95E + 00 9.64E + 00 1.41E + 01 1.61E + 01 1.69E + 01 1.73E + 01
NSCstr_PKG # 2.51E + 00 2.48E + 00 2.44E + 00 2.42E + 00 2.41E + 00 2.41E + 00
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bp mm Hg 10 20 40 60 80 100
PP_NaKCl # 9.92E + 03 9.92E + 03 9.92E + 03 9.92E + 03 9.92E + 03 9.92E + 03
PP_P_NaKCl # 7.73E + 01 7.73E + 01 7.73E + 01 7.73E + 01 7.73E + 01 7.73E + 01
IP3R # 1.99E + 03 1.99E + 03 1.99E + 03 1.99E + 03 1.99E + 03 1.99E + 03
IP3R_IRAG_PKG # 9.93E + 00 9.93E + 00 9.93E + 00 9.93E + 00 9.93E + 00 9.93E + 00
SERCA # 9.29E + 02 9.22E + 02 9.02E + 02 8.84E + 02 8.72E + 02 8.64E + 02
SERCA_P # 7.10E + 01 7.81E + 01 9.82E + 01 1.16E + 02 1.28E + 02 1.36E + 02
KATP # 1.55E + 02 1.55E + 02 1.55E + 02 1.55E + 02 1.55E + 02 1.55E + 02
KATP_PKA # 4.24E + 00 4.24E + 00 4.24E + 00 4.24E + 00 4.24E + 00 4.24E + 00
KATP_PKC # 1.41E + 02 1.41E + 02 1.41E + 02 1.41E + 02 1.41E + 02 1.41E + 02
#, the number of molecules.
aALL here indicates the sum of the currents conducted by dephosphorylated and all phosphorylated species.
bALL here indicates the sum of all ionic currents.
cJust the Cl current; the total current carried by NaKCl is zero.
Ta b l e  S 3
Determinants of oscillations






I.SERCA_max 0.8 pA 0.64 pA 2.2 2.2
I.SERCA_max 0.8 pA 0.96 pA 3.3 3.3
Ca.SRcen variable 97.2 µM 0 0
Ca.SRcen variable 108 µM 3.0 3.0
Ca.SRcen variable 118.8 µM 5.3 5.3
Ca.SRcen variable 129.6 µM 0 0
Ca.SRper variable 65.8 µM 0 0
Ca.SRper variable 82.3 µM 0 0
Ca.SRper variable 98.8 µM 0 0
VOL.SRper 0.56 fL 0.45 fL 3.1 3.1
VOL.SRper 0.56 fL 0.67 fL 2.8 2.8
RyR.T 3,000 #/cell 3,600 #/cell 3.9 3.9
RyR.T 3,000 #/cell 3,300 #/cell 3.4 3.4
RyR.T 3,000 #/cell 2,700 #/cell 2.3 2.3
RyR.T 3,000 #/cell 2,400 #/cell 0 0
K.RyR_Ca_min; …_max 4 µM; 10 µM 6.0 µM 5.4 5.4
K.RyR_Ca_min; …_max 4 µM; 10 µM 7.5 µM 2.2 2.2
K.RyR_Ca_min; …_max 4 µM; 10 µM 9.0 µM 0 0
Ca.jun input to RyR variable 0.56 µM 0 0
Ca.jun activation of RyR variable 0.7 µM 0 0
Ca.jun activation of RyR variable 0.84 µM 0 0
K.RyR_Ca_inh 3 µM 2.4 µM 3.1 3.1
K.RyR_Ca_inh 3 µM 3.6 µM 2.9 2.9
K.RyR_Ca_inh 3 µM 100 µM 2.8 2.8
VOL.jun 0.13 fL 0.104 fL 3.2 3.2
VOL.jun 0.13 fL 0.156 fL 2.6 2.6
Ca.jun_fixed input to BK variable 0.56 µM 4.8 0
Ca.jun_fixed input to BK variable 0.7 µM 4.0 0
Ca.jun_fixed input to BK variable 0.84 µM 2.8 0
aFrequency in the interval from 150 to 155 s during a 300-s simulation at 60 mm Hg.
S14 Model of arterial smooth muscle myogenic response
Ta b l e  S 5
Dose–response parameters for A, A + ATP, A, EET, and NO
Effectors Frequency Variable (Z) EC50 Zinf-Z0 n
hz µM mV or µM
A steady V 0.27 15.1 1.36
Ca.in 0.41 0.103 1.20
A+ATP steady V 0.20 14.9 1.28
Ca.in 0.22 0.100 1.26
A 0.1 V 2.73 12.3 1.46
Ca.in 2.79 0.065 1.52
A 0.2 V 1.67 14.4 1.34
Ca.in 2.22 0.092 1.29
A 0.4 V 0.93 15.3 1.30
Ca.in 1.30 0.101 1.24
A+ATP 0.1 V 1.59 11.2 1.33
Ca.in 1.68 0.079 1.36
A+ATP 0.2 V 1.16 14.0 1.42
Ca.in 1.25 0.103 1.23
A+ATP 0.4 V 0.72 15.1 1.39
Ca.in 0.73 0.103 1.25
A steady V 0.83 15.1 1.21
Ca.in 0.57 0.064 1.23
EET steady V 0.54 20.0 1.45
Ca.in 0.24 0.057 1.39
NO steady V 0.46 8.7 0.81
Ca.in 0.40 0.046 0.79
Parameters of the Hill equation, Z = Zinfan/(Qn + an), where Z = Z  Z0, Z0 = variable at 0 effector, Zinf = variable at infinite effector concentration, a 
= [agonist], Q = EC50, and n = the Hill coefficient, were obtained by a nonlinear least-squares error fit of simulated data (see Fig. 6).
Ta b l e  S 4
Fractional changes in Vm, Cain, and individual components per change in parameter
Parameter <V.m> <Ca.in> Local output Local output
Fractional changesa Fractional changesa Fractional changesb
(1/mV) (1/mV) (1/mV)
V.Kv 0.59% 0.70% I.Kv 8.13%
V.ClA 0.53% 0.58% I.ClA 3.42%
V.CaV_act 0.66% 3.14% I.CaV_ALL 10.16%
V.BK_closed 0.11% 0.05% I.BK_ALL 3.11%
V.BK_open 0.34% 0.27% I.BK_ALL 4.08%
aV.m and Ca.in were simulated at six intravascular pressures with the parameters increased and decreased by 2 mV to obtain the perturbed values. The 
mean of the six values of {|(z.perturbed  z.normal)/z.normal|}/2, where z is either V.m or Ca.in, was calculated. The average of the means for 2 and 2 
mV are presented.
bAs in footnote a, except that z is the value of the individual component dependent on the parameter.
Table S6 is available as a Word document.
Model equations (Mathcad program) are available in a PDF file.
A PDF file of reaction schemes for -adrenergic signaling, -adrenergic signaling, NaKCl cotransporter, NCX ex-
changer, and P2XR is also available.
Table S6 
Normal parameters 
   
Parameter Units Values Notes 
t1 s 300 0 to t1 is solution interval. 
N1   12000 Number of points saved for calculations and plotting. 
TOL   1.00E-05 
Precision of derivatives and integrals; convergence criterion in a 
solve block.  
CTOL   1.00E-03 
Criterion for acceptable deviation from a constraint in a solve 
block. 
a s 250 Start-time of means. 
b s 300 End-time of means. 
αAR       
αAR.T #/cell 6.00E+03 
Calculated from ~100 fmol/mg protein in rat aorta (Faber et al., 
2001). 
k.αAR_on 1/(μM*s) 1.00E+00 From  k.αAR_off/ k.αAR_on = 10 μM (Bennett et al., 2005). 
k.αAR_off 1/s 1.00E+01  From  k.αAR_off/ k.αAR_on = 10 μM (Bennett et al., 2005). 
k.αAR_P 1/s 2.00E-02  0.1 (Bennett et al., 2005). 
k.αAR_endo 1/s 2.00E-02  0.006 in ref (Bennett et al., 2005). 
k.αAR_recyc 1/s 1.00E-02  (Schofl et al., 1993). 
AC       
AC.T # 6.00E+03  Assume AC.T = βAR.T. 
k.AC0_Gs_on cell/(#*s) 4.00E-05  Local fitc of βAR dose response (Garland et al., 2011). 
k.AC1_Gs_off 1/s 5.00E-01  Local fit of βAR dose response. 
k.AC1_ATP 1/s 2.00E+02  From   ~100/s (Dessauer and Gilman, 1997) 
k.PKA_AC 1/s 1.00E-02  Local fit of βAR dose response. 
k.PP_AC 1/s 1.00E-02  Local fit of βAR dose response. 
k.AC0_ATP 1/s 1.00E-01 
Compatible with basal [cAMP] =  ~0.2 μM in PKA  microdomain 
(Iancu et al., 2008). 
βAR       
βAR.T #/cell 6.00E+03 Assume = alphaR.T.  
k.βAR_on 1/(μM*s) 2.00E-01 Local fit  (Garland et al., 2011). 
k.βAR_off 1/s 4.00E+00 Local fit. 
k.βAR_P 1/s 4.00E-03 Local fit. 
k.βAR_endo 1/s 4.00E-03 Local fit. 
k.βAR_recyc 1/s 4.00E-03 Local fit. 
BK       
BK.T #/cell 1.50E+03  Global fitb;  ~3000 channels per cell (Wellman and Nelson, 2003). 
perm.BK cm3/(#*s) 4.00E-13 
From   γ = 212 pS in symmetrical 140 mM K+ (Mistry and Garland, 
1998). 
K.BK_closed μM 4.72E+00  (Bao and Cox, 2005) 
K.BK_open μM 8.00E-01  (Bao and Cox, 2005) 
V.BK_open mV -3.40E+01  (Bao and Cox, 2005) 
V.BK_closed mV 8.00E+01  (Bao and Cox, 2005) 
z.BK_J alg. chrg 5.70E-01  (Bao and Cox, 2005) 
z.BK_L alg. chrg 4.10E-01  (Bao and Cox, 2005) 
L.BK none 2.50E-06  (Bao and Cox, 2005) 
L.BK_PKA none 7.50E-06  Hypothetical.d  
L.BK_PKC none 8.33E-07  Hypothetical.  
L.BK_PKG none 7.50E-06  Hypothetical.  
k.PKA_BK 1/s 2.00E+01  Hypothetical.  
k.PKC_BK 1/s 2.00E+01  Hypothetical.  
k.PKG_BK 1/s 4.00E+01  Hypothetical.   
k.PP_BK 1/s 2.00E+01  Hypothetical.  
CaV       
CaV.T #/cell 3.00E+03  Global fit.   
perm.CaV cm3/(#*s) 1.21E-13 From   γ = 3.5 pS at 2 mM Ca2+ externally (Rubart et al., 1996). 
V.CaV_act mV 6.20E+00  (Rubart et al., 1996) 
ξ.CaV_act mV 9.30E+00  (Rubart et al., 1996) 
V.CaV_PKC_act mV 1.20E+00  Hypothetical.  
V.CaV_PKG_act mV 1.12E+01  Hypothetical.  
K.CaV_inh μM 1.20E-00  Global fit.  
k.PKC_CaV 1/s 2.00E+01  Hypothetical.  
k.PKG_CaV 1/s 4.00E+01  Hypothetical.  
k.PP_CaV 1/s 2.00E+01  Hypothetical.  
Cl.A=Cl(Ca)       
Cl.AT #/cell 2.50E+03 Global fit.   
perm.ClA cm3/(#*s) 1.60E-14 From   γ = 8.3 pS with symmetrical 140 mM Cl- (Yang et al., 2008). 
zeta.ClA alg. chrg. 2.00E+00 Local fit   (Yang et al., 2008). 
V.ClA mV 0.00E+00 Local fit. 
K.ClA_Ca_act_max μM 4.10E+00 Local fit. 
K.ClA_Ca_act_min μM 3.00E-01 Local fit. 
K.ClA_Ca_inh μM 4.00E+01 Local fit. 
n.ClA none 2.60E+00 Local fit. 
G.q       
G.qT #/cell 6.00E+03  Assumed equal to αAR.T 
k.Gq0_GDP_αAR_on cell/(#*s) 2.00E-05 Local fit to obtain αR dose-response (Bennett et al., 2005). 
k.Gq1_GDP_αAR_off 1/s 1.00E+00 Local fit to obtain αR dose-response. 
k.Gq1_GDP_GTP_exch 1/s 1.00E+00 Local fit to obtain αR dose-response. 
k.Gq_GTPase 1/s 5.00E-02 Local fit to obtain αR dose-response. 
G.s       
G.sT #/cell 6.00E+03  Assumed equal to βAR.T 
k.Gs0_GDP_βAR_on cell/(#*s) 1.00E-05 Local fit to obtain βR dose-response. 
k.Gs1_GDP_βAR_off 1/s 5.00E-01 Local fit to obtain βR dose-response. 
k.Gs1_GDP_GTP_exch 1/s 1.00E+00 Local fit to obtain βR dose-response. 
k.Gs_GTPase 1/s 5.00E-02 Local fit to obtain βR dose-response. 
IP3R       
IP3.T #/cell 2.00E+03 Global fit.  
perm.IP3R cm3/(s*#) 1.10E-13 From   γ = 80 pS in symmetrical 50 mM Ba2+ (Tu et al., 2005). 
K.IP3R_IP3 μM 3.50E-01  ~0.3 µM (IP3R  type 1) (Narayanan et al., 2012). 
K.IP3R_IRAG_PKG_IP3 μM 8.00E-01   Hypothetical.  
n.IP3R_IP3 none 3.00E+00   Hypothetical.  
K.IP3R_Ca_max μM 1.00E+00   Hypothetical.  
K.IP3R_Ca_min μM 1.00E-01  ~0.2 µM (Narayanan et al., 2012) 
K.IP3R_Ca_inh μM 3.00E-01  ~0.4 µM (Narayanan et al., 2012) 
n.IP3R_Ca_inh none 2.50E+00   Hypothetical.  
K.IP3R_CaSR μM 1.40E+02   Hypothetical.  
n.IP3R_CaSR none 2.50E+00   Hypothetical.  
n.IP3R_Ca_act none 3.00E+00   Hypothetical.  
k.PKG_IP3R_IRAG 1/s 2.00E+01   Hypothetical.  
k.PP_IP3R_IRAG_PKG 1/s 2.00E+01   Hypothetical.  
KATP       
KATP.T #/cell 3.00E+02  Global fit.   Upper limit ~500/cell (Quayle et al., 1997). 
P.open_KATP none 5.00E-03   Hypothetical.  
P.open_KATP_PKA none 1.20E-01   Hypothetical.  
k.PKA_KATP 1/s 2.00E+00   Hypothetical.  
k.PKCε_KATP 1/s 2.00E+00   Hypothetical.  
k.PP_KATP_PKA 1/s 2.00E-01   Hypothetical.   
k.PP_KATP_PKCε 1/s 2.00E-01   Hypothetical.   
perm.KATP cm3/(#*s) 7.00E-14  From   γ = 35 pS in symmetrical 140 mM KCl (Quayle et al., 1997). 
Kv       
Kv.T #/cell 2.70E+02 Global fit.  
perm.Kv cm3/(#*s) 2.50E-14 
From   γ = 12 pS ,130 mM KCl inside, 3.5 mM outside (Kwan et al., 
2006). 
V.Kv mV -2.00E+01 (Ledwell and Aldrich, 1999; Zhang et al., 2001) 
ξ.Kv mV 7.00E+00 (Ledwell and Aldrich, 1999) 
LEAKS       
Na.leakT #/cell 0.00E+00  Global fit.  
perm.Na_leak cm3/(s*#) 1.00E-15  Hypothetical.  
K.leakT #/cell 2.00E+01  Global fit.  
perm.K_leak cm3/(s*#) 1.00E-15  Hypothetical.  
Cl.leakT #/cell 2.20E+01  Global fit.  
perm.Cl_leak cm3/(s*#) 1.00E-15  Hypothetical.  
Ca.leakT #/cell  1.30E+01 Global fit. 
perm.Ca_leak cm3/(s*#) 1.00E-14 Hypothetical. 
NaK       
I.NaKmax pA/cell 6.00E+01  2.3 A/Farad * 25 pFarad/cell (Kapela et al., 2008). 
K.NaK_Kex mM 1.60E+00  (Kapela et al., 2008) 
K.NaK_Nain mM 2.20E+01  (Kapela et al., 2008) 
n.NaK_Na none 2.50E+00  Adjusted from 1.7 (Kapela et al., 2008). 
n.NaK_K none 1.10E+00  (Kapela et al., 2008) 
Δµ..ATP J/mol -5.00E+04  (Bergman, 2010) 
NaKCl       
NaKCl.T #/cell 1.00E+04  Global fit.  
L.NaKCl_Na mM 3.20E+01 Adjusted  from 18 mM (Somasekharan et al., 2012). 
L.NaKCl_K mM 2.70E+01 Adjusted  from 1.6 mM (Somasekharan et al., 2012). 
L.NaKCl_Cl mM 6.30E+01 Adjusted  from 48 mM (Somasekharan et al., 2012). 
α.NaKCl_4 1/s 5.00E+04 
Hypothetical.   Note that α.NaKCl_0  =  
β.NaKCl_0*α.NaKCl_4/β.NaKCl_4. 
β.NaKCl_0 1/s 5.00E+04 Hypothetical.    
β.NaKCl_4 1/s 4.00E+04 Hypothetical.    
ε.NaKCl_PKC none 2.00E+00 Hypothetical.    
k.PKC_NaKCl 1/s 2.00E+01 Hypothetical.    
PP.NaKCl_T #/cell 1.00E+04 Assumed in 1:1 complex with NaKCl.T  
k.PP_NaKCl 1/s 2.00E+01 Hypothetical.    
k.PP_P_NaKCl 1/s 4.00E+01 Hypothetical.    
k.PKA_PP_NaKCl 1/s 2.00E+01 Hypothetical.    
k.PKG_PP_NaKCl 1/s 2.00E+01 Hypothetical.    
k.PP_PP_NaKCl 1/s 2.00E+01 Hypothetical.    
NCX       
NCX.T #/cell 1.60E+03 Global fit.  
K.NCX_Na mM 1.00E+02 
Hypothetical.  30 mM =  ~(k.n1*k.n2*k.n3)^0.33 (Kang and 
Hilgemann, 2004) 
K.NCX_Ca μM 8.00E-02 Hypothetical.   ~3 μM (Kang and Hilgemann, 2004) 
α.NCX_0 1/s 3.00E+04 Hypothetical.    
α.NCX_4 1/s 3.00E+04 (Kang and Hilgemann, 2004) 
β.NCX_4 1/s 5.00E+04 Hypothetical.    
K.NCX_act_Ca μM 1.00E-01 Comparable parameter ~0.15 – 0.4 µM (Reeves et al., 2007). 
n.NCX_act none 2.00E+00 (Reeves et al., 2007) 
NSCeet       
NSCeet.T #/cell 4.00E+01  Global fit.  
perm.NaNSCeet cm3/(#*s) 1.30E-13 Assumed equal to  perm.KNSCeet. 
perm.KNSCeet cm3/(#*s) 1.30E-13 From   γ = 45 pS , symmetrical 98 mM KCl (Loukin et al., 2010). 
perm.CaNSCeet cm3/(#*s) 9.00E-13 Based on p.Ca/p.Na = 6.9 (Voets et al., 2002). 
K.NSCeet_EET μM 5.00E-02 Local fit (Earley et al., 2005). 
n.NSCeet none 1.00E+00 Local fit (Earley et al., 2005). 
V.NSCeet_min 
 
mV -1.00E+01 Local fit (Loukin et al., 2010) 
V.NSCeet_max 
 
mV 50 Local fit (Loukin et al., 2010) 
ξ.NSCeet mV 1.00E+01 Local fit (Loukin et al., 2010) 
NSCne       
NSCne.T #/cell 3.10E+01 Global fit.  
perm.NaNSCne cm3/(#*s) 3.30E-14 From   γ = 15 pS , symmetrical 126 mM Na+/Cs+ (Saleh et al., 2006). 
perm.KNSCne cm3/(#*s) 3.30E-14  Assumed equal to perm.NaNSCne. 
perm.CaNSCne cm3/(#*s) 1.50E-13  p.Ca/p.Na = 4.54 (Kapela et al., 2008). 
K.NSCne_DAG μM 1.20E+00  Hypothetical.  
K.NSCne_Ca_act μM 2.00E-01  Hypothetical.  
K.NSCne_Ca_inh μM 1.00E+00  Hypothetical.  
n.NSCne none 2.00E+00  Hypothetical.  
NSCstr       
NSCstr.T #/cell 2.61E+02 Global fit.  
perm.NaNSCstr cm3/(#*s) 3.30E-14 Assumed to equal perm.NaNSCne 
perm.KNSCstr cm33/(#*s) 3.30E-14 Assumed to equal perm.KNSCne 
perm.CaNSCstr cm3/(#*s) 1.50E-13 Assumed to equal perm.CaNSCne 
bp.50 mm Hg 3.00E+02 Global fit.  
K.NSCstr_DAG μM 1.38E+00 Global fit.  
K.NSCstr_Ca_act μM 1.70E+00 Global fit.  
K.NSCstr_Ca_inh μM 1.00E+02 Global fit.   
n.NSCstr_DAG none 2 Global fit.  
n.NSCstr_Ca none 1.00E+00 Global fit.  
n.NSCstr_bp none 1.00E+00 Global fit.  
K.NSCstr_PKC_Ca_act μM 1.00E+00 Hypothetical.  
K.NSCstr_PKG_Ca_act μM 4.00E+00 Hypothetical.  
k.PKC_NSCstr 1/s 3.00E+00 Hypothetical.  
k.PKG_NSCstr 1/s 2.00E+01 Hypothetical.   
k.PP_NSCstr   1.00E+01 Hypothetical.  
PDE       
k.PKA_PDE 1/s 1.00E+01 Hypothetical.  
k.PKG_PDE 1/s 1.00E+01 Hypothetical.   
k.PP_PDE 1/s 1.00E+01 Hypothetical.  
n.PDE none 1.00E+00 Hill coefficient for activation of both PDEs 
PDE.cAMP_T μM 1.00E-02 Hypothetical.  
K.PDE_cAMP μM 8.00E+00 Hypothetical.   
K.PDE_cAMP_P μM 3.00E+00 Hypothetical.  
k.PDE_cAMP 1/(μM*s) 1.00E+01 Hypothetical.  
PDE.cGMP_T μM 1.00E-02 Hypothetical.   
K.PDE_cGMP μM 8.00E+00 Hypothetical.  
K.PDE_cGMP_P μM 3.00E+00 Hypothetical.   
k.PDE_cGMP 1/(μM*s) 1.00E+01 Hypothetical.  
PKA_PKC_PKG_PKCe       
K.PKA_cAMP μM 4.00E+00 
In the range between basal and stimulated [cAMP] (Gesellchen et 
al., 2006).  
n.PKA_cAMP none 2.00E+00 Hill coefficient for activation. 1.6 in (Herberg et al., 1994). 
K.PKC_DAG μM 5.00E-01  
K.PKC_Ca μM 2.00E-01  
n.PKC_Ca none 2.00E+00 Added 6/3/13 to SM model 61. 
K.PKG_cGMP μM 3.00E+00   
n.PKG_cGMP none 2.00E+00 Hill coeff for activation 
K.PKCε_DAG μM 1.70E+00   
K.PKD_DAG μM 1.70E+00   
PLC       
PLC.T #/cell 6.00E+03  Assumed equal to αAR.T. 
k.PLC_PIP_on cell/(#*s) 1.00E-06  Hypothetical basal rate.  PLC is assumed to be membrane-bound. 
k.PLC_PIP_off 1/s 1.00E+02  Hypothetical basal rate. 
k.PLC_PIP_hyd 1/s 2.00E+01  Hypothetical basal rate. 
k.PLC_Gq0_GTP_on cell/(#*s) 2.00E-04 
Local fit (Waldo et al., 2010). Both PLC and Gq are assumed to be 
membrane-bound and to diffuse and collide in two dimensions. 
k.PLC_Gq0_GTP_off 1/s 2.00E-02 Local fit (Waldo et al., 2010).  
k.PLC_Gq0_GTP_hyd 1/s 1.00E-01 Hypothetical. 
k.PLC_Gq0_GTP_PIP_o
n cell/(#*s) 3.00E-06 Hypothetical. 
k.PLC_Gq0_GTP_PIP_o
ff 1/s 1.00E+01 Hypothetical. 
k.PLC_Gq0_GTP_PIP_h
yd 1/S 8.00E+01 Hypothetical. 
k.PKA_PLC_Gq0_GTP 1/s 1.00E+01 Hypothetical. 
k.PKC_PLC_Gq0_GTP 1/S 1.00E+01 Hypothetical. 
k.PLC_P_Gq0_GTP_on cell/(#*s) 5.00E-06 Hypothetical. 
k.PLC_P_Gq0_GTP_off 1/s 1 Hypothetical. 
k.PP_PLC 1/s 2 Hypothetical. 
PIP.T #/cell 1.00E+07 Global fit.  
k.met_DAG 1/s 0.09 Global fit. Unspecified pathway of metabolic removal. 
k.met_IP3 1/s 0.09 Global fit. Unspecified pathway of metabolic removal. 
PMCA       
I.PMCA_max pA/cell 1.80E+01 Global fit.  
K.PMCA_Ca μM 4.00E-01 Local fit.  (Brini and Carafoli, 2011) 
n.PMCA_Ca none 3.00E+00 Global fit.   
P2XR       
P2XR.T #/cell 1.00E+02 Global fit.  
perm.NaP2XR cm3/s/cell 4.30E-14 
From   γ = 20 pS , symmetrical 130 mM Na+ (Benham and Tsien, 
1987). 
perm.KP2XR cm3/s/cell 4.30E-14 Assumed equal to perm.NaP2XR 
perm.CaP2XR cm3/s/cell 1.30E-13 p.Ca/p.Na = 3 (Benham and Tsien, 1987). 
k.P2XR_0_on 1/(s*μMnH) 1.00E+01 Local fit.   EC50 for ATP = 0.67 μM (Lorinczi et al., 2012). 
k.P2XR_3_off 1/s 1.00E+02 Calculated by microscopic reversibility in top cycle of reactions.  
n_P2XR none 2.00E+00 Local fit  (Lorinczi et al., 2012).   
k.P2XR_3_act 1/s 1.00E+02 Local fit  (Lorinczi et al., 2012).   
k.P2XR_3_deact 1/s 1.00E+01 Local fit  (Lorinczi et al., 2012).   
k.P2XR_3_act_desens 1/s 1.00E+00 Local fit.    τ.desens  ~ 250 ms (Lalo et al., 2011). 
k.P2XD_3_resens 1/s 1.00E-02 Local fit.     
k.P2XR_0_desens 1/s 1.00E-01 Local fit.     
k.P2XD_0_resens 1/s 1.00E+00 Local fit.     
k.P2XD_0_on 1/(s*μMnH) 1.00E+01 Local fit.     
k.P2XD_3_off 1/s 1.00E-02 Local fit.     
k.P2XD_0_PKD_on 1/(s*μMnH) 1.00E+00 Hypothetical.  
k.P2XD_3_PKD_off 1/s 1.00E+00 Hypothetical.  
k.PKD_P2XD_3 1/s 1.00E+00 Hypothetical.  
k.PP_P2XD_0_PKD 1/s 1.00E+00 Hypothetical.  
RyR.jun       
RyR.T #/cell 3.00E+03 Global fit.    ~15 per junction (Lifshitz et al., 2011). 
perm.RyR cm3/(s*#) 2.00E-13 From   γ = 150 pS in symmetrical 50 mM Ca2+ (Meissner, 2004). 
K.RyR_Ca_SR μM 8.00E+02 Hypothetical.  
n.RyR_Ca_SR none 5.00E-01 Hypothetical.  
K.RyR_Ca_jun_max μM 1.00E+01 EC50_Ca.cyt ~ 10 μM (Guo et al., 2012). 
K.RyR_Ca_jun_min μM 4.00E+00 Hypothetical.   
n.RyR_Ca_jun none 2.00E+00 Hypothetical.  
K.RyR_Ca_inh μM 3.00E+00 
Hypothetical.  Assumed that RyR is saturated with calmodulin (Xu 
and Meissner, 2004). 
n.RyR_Ca_inh none 3.00E+00 Hypothetical.  
k.PKA_RyR 1/s 4.00E+01 Hypothetical.  
k.PKC_RyR 1/s 4.00E+01 Hypothetical.  
k.PP_RyR 1/s 4.00E+01 Hypothetical.  
f.RyR_PKA_min none 4.00E-01 Hypothetical.  
f.RyR_PKC_max none 5.00E+00 Hypothetical.  
SERCA       
SERCA.T #/cell 1.00E+03 Arbitrary denominator in fractions of different forms of SERCA. 
I.SERCA_max pA/cell 8.00E-01 Global fit.  
K.SERCA_Ca μM 2.00E-01 
 0.31 µM for SERCA2a and 0.17 µM for SERCA2b (Missiaen et al., 
1991). 
n.SERCA none 1.60E+00 Global fit.  
K.SERCA_inh_Ca_SRce μM 1.00E+02 Global fit.  
n 
K.SERCA_P_Ca μM 1.00E-01 Global fit.  
k.PKA_SERCA 1/s 2.00E+01 Hypothetical 
k.PKC_SERCA 1/s 2.00E+01 Hypothetical 
k.PKG_SERCA 1/s 2.00E+01 Hypothetical  
k.PP_SERCA 1/s 2.00E+01 Hypothetical 
sGC       
GC.T μM 1.00E-02   
k.GC0_NO_on 1/(μM*s) 3.00E+02 Adjusted   from 7E2 (1/(μM*s)) (Yang et al., 2005) 
k.GC1_NO_off 1/s 2.00E+02 Adjusted   from 1E2 (1/s) (Yang et al., 2005) 
k.GC1_NO_on 1/(μM*s) 2.00E+02 Local fit  
k.GC2_NO_off 1/s 2.00E+02 Local fit  
k.GC1_act 1/s 1.00E+00 Local fit  
k.GC1_deact 1/s 1.00E-01 Local fit  
k.GC2_act 1/s 1.00E+01 Local fit  
k.PKG_GC 1/s 1.00E+01 Hypothetical 
k.PP_GC 1/s 1.00E+01 Hypothetical 
k.GC_act_GTP 1/s 1.00E+01 Local fit 
k.GC_basal_GTP 1/s 1.00E-01 Adjusted to yield basal [cGMP] ~ basal [cAMP] . 
CAPAC & VOLS       
C.m Farads/cell 2.50E-11  (Kapela et al., 2008) 
VOL.cell L/cell 1.00E-12  (Yang et al., 2005) 
VOL.SRper L/cell 5.60E-16 
180 peripheral ER discs,  radius 100 nm, height 100 nm (Moore et 
al., 2004) 
VOL.jun L/cell 1.30E-16  180 junctions, radius 100 nm, height 23 nm. 
VOL.SRcen L/cell 7.00E-14 
 Floyd and Wray (Floyd and Wray, 2007) state 1.5% to 7.5% of cell 
volume. 
VOL.NSCstr L/cell 6.30E-17 Approx. 260 hemispheres, 49 nm in radius. 
BUFFERS       
BUF.T μM 3.00E+02  Kapela et al: 100 μM calmodulin, 100 μM other Ca buffers  
k.BUF_on 1/(μM*s) 2.20E+01 
 Geometric  mean of k.on for calmodulin and calbindin sites (Keller 
et al., 2008). 
k.BUF_off 1/s 7.70E+01 
 Geometric  mean of k.off for calmodulin and calbindin sites (Keller 
et al., 2008). 
BUF.jun_T μM 3.00E+02  =BUF.T 
BUF.NSCstr_T μM 3.00E+02  =BUF.T 
CSQ.SRcen_T μM 3.00E+02  =BUF.T 
CSQ.SRper_T μM 3.00E+02  =BUF.T 
k.CSQ_on 1/(μM*s) 2.00E+00 K.CSQ = 0.8 mM (Sobie et al., 2002) 
k.CSQ_off 1/s 1.60E+03  = k.CSQ_on* K.CSQ 
INTRACELL FLUX       
λ.jun_cyt L/s 8.00E-13 Equilibration time-constant = VOL.jun/ λ.jun_cyt = ~160 μs 
λ.cen_per L/s 1.60E-14 Equilibration time-constant = VOL.per/ λ.cen_per = 35 ms 
λ.NSCstr_cyt L/s 4.00E-13 Equilibration time-constant = VOL.NSCstr/ λ.NSCstr_cyt = ~160 μs 
IONS & T       
T oK 3.10E+02   (Knot and Nelson, 1998) 
Na.ex mM 1.43E+02   (Knot and Nelson, 1998) 
K.ex mM 5.90E+00   (Knot and Nelson, 1998) 
Ca.ex μM 1.60E+03   (Knot and Nelson, 1998) 
Cl.ex mM 1.27E+02   (Knot and Nelson, 1998) 
        
Text preceded by a period in the table is subscripted in the program. 
apermx = RTγx/(z2F2cx), where cx is concentration of ion species x in mol/cm3 at which γx, the single-channel conductance, 
was determined; conceptually, permx = px/nx, where px is the permeability (cm/s) of a membrane to x due to a given 
channel and nx  is the number  of these channels per cm2 of membrane. 
bGlobal fit to V.exp and Ca.exp vs pressure (Knot, 1998 #170). 
cLocal fit , at least qualitatively, to similar behavior in the referenced work, given the local model adopted here. 
dHypothetical indicates that the value of the parameter  yields plausible behavior of the local model. 
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 of NCX. In X three Na binding sites are accessible to the extracellular medium
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The K are equilibrium dissocation constants, and  and  are
isomerization rate constants.  It is assumed that X  and Y  have one net negative charge that
moves; i.e., three negative charges associated with the three Na binding sites and, on the
opposite side of the membrane, two negative charges associated with the Ca binding site.
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1SUPPLEMENTARY EQUATIONS
Parameters values are entered in Excel and copied to Mathcad (see below). Results obtained with each set of parameters are copied back to
Excel. Units of variables are mV for electrostatic potential, μM for concentrations of all soluble components including Ca, and mM for Na, K, and Cl.
Total fluxes are in fmol/s, and total currents are in pA. Parameter units are listed in the table of normal parameters (Table S1).
Comments are in Arial font; Mathcad statements are in Times New Roman font.
A. Effector concentrations
These are copied from Excel as row vectors and converted to column vectors. Ordinarily, the concentration (or
pressure) of only one effector will change in a run. As written, six intravascular pressures are input, but any number can be input.
The concentrations of the other effectors are constant (in this case zero).. 
ATP. extracellular α1-adrenergic receptor agonist
[Seq.A.1] ATP1_excel 0 0 0 0 0 0( ) [Seq.A.3] alphaA1_excel 0 0 0 0 0 0( )
[Seq.A.2] atp1 ATP1_excelT [Seq.A.4] alphaA1 alphaA1_excelT
β1-adrenergic receptor agonist Intravascular pressure
[Seq.A.7] bp1_excel 10 20 40 60 80 100( )[Seq.A.5] betaA1_excel 0 0 0 0 0 0( )
[Seq.A.8] bp1 bp1_excelT[Seq.A.6] betaA1 betaA1_excelT
Nitric oxideEpoxyeicosatrienoic acid
[Seq.A.9] eet1_excel 0 0 0 0 0 0( ) [Seq.A.11] nox1_excel 0 0 0 0 0 0( )
[Seq.A.10] eet1 eet1_excelT [Seq.A.12] nox1 nox1_excelT
For simulations at multiple effector concentrations or intravascular pressures, one of the above vectors is assigned to
the effector concentration vector, eff_conc1. The parameter name of the effector that varies (ATP1, αA1, βA1, BP1, EET1, or
NO1] must be the argument of W( ).  Only the effector vector assigned to eff_conc1 is called and this vector can be of any
length greater or equal to 1. A second effector can co-vary if set equal to, or a multiple of, the first.
2 Define eff_conc1
[Seq.A.13] eff_conc1 bp1
In the EFFECTORS vector below, each effector is assigned two concentrations; conc0 and conc1. The effector is at conc0
from t=0 to t=τ1, rises to conc1 from τ1 to τ2, is steady from τ2 to τ3, and then falls to conc0. These are the fixed concentrations of
the effectors not specified as the varying argument of W( ) (see solve block). The application of multiple pulses requires additional
parameters specifying the number of pulses and the pulse duration and the inter-pulse interval. Solutions for multiple conc1  for a
given effector, specified by eff_conc1, are obtained by automatic successive runs. During these runs (or one run if eff_conc1 has a
single value), any of the other effectors can also be added but at the same concentrations in successive runs. 
[Seq.A.15][Seq.A.14]























































































































































































































































































































































































































































































































































































































































A table, EFF_NAMES_VALUES, is generated showing the effector parameter names and values.































































































































































































































B. All other parameters



































































































































"a (integration  start time)"















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































[Seq.B.3] PARA_AUGMENT augment PARA_NAMES PARAS( )
19






































"a (integration  start time)" 2.5E+002



























Assignment of parameter values, as sub-matrices of PARAS, to parameters
[Seq.B.7][Seq.B.5] [Seq.B.6]





















































































BK submatrix PARAS 32 47 0 0( ) CaV submatrix PARAS 50 59 0 0( )















































































































































































































IP3R submatrix PARAS 98 111 0 0( ) KATP submatrix PARAS 114 121 0 0( )









































































































































































































NaKCl submatrix PARAS 147 161 0 0( )
































































































































































































































































































































































































































































































































































































































































































































































































































[Seq.B.67-73] NA 6.022 10
23
 R 8.314 F 96487 zNa 1 zK 1 zCa 2 zCl 1
Frequently used combinations
[Seq.B.74] ν NA VOLcell [Seq.B.75] β
F
1000 R T( )

C. APPLICATION OF EFFECTORS
 Change in concentration of αA from αA0 to αA1 and its return to αA0.
ταA1, start application; ταA2, start plateau; ταA3, start wash-out; καA1,rise rate constant;
καA2,wash-out rate constant. Power of 2 rounds the corners. 
αA_steady αA0 αA1 t  αA0 0 t ταA1if
αA0 αA1 αA0  1 e







 ταA1 t ταA2if
αA0 αA1 αA0  1 e







 ταA2 t ταA3if
αA0 αA1 αA0  1 e












Pulsatile application of αA, raising concentration from αA0 to αA1.
τpulse_init, initial pulse start; Δτpulse_on, pulse-on duration;Δτpulse_off,  pulse-off duration; ncycles, number of on-off cycles.
cycle_period Δτpulse_on Δτpulse_off[Seq.C2] [Seq.C3] tcycles_end ncycles cycle_period τpulse_init
Define pulse_number(t) that returns which pulse, if any, t is in, and pulse_start(t) that returns the start time of that pulse. 
pulse_number(t) can exceed n.cycles,  the specified number of cycles, but only n.cycles will occur before  t > tcycles_end.
30









1 [Seq.C5] pulse_start t( ) τpulse_init pulse_number t( ) 1( ) cycle_period[Seq.C4]
αA_rise αA0 αA1 t  αA0 αA1 αA0  1 e

















καA2 t pulse_start t( ) Δτpulse_on 

αA_pulse αA0 αA1 t  alphaA αA_rise αA0 αA1 t  τpulse_init t tcycles_end 0 t pulse_start t( ) Δτpulse_on if




Change in concentration of ATP from ATP0 to ATP1 and its return to ATP0.
ATP_steady ATP0 ATP1 t  ATP0 0 t τatp1if
ATP0 ATP1 ATP0  1 e







 τatp1 t τatp2if
ATP0 ATP1 ATP0  1 e







 τatp2 t τatp3if
ATP0 ATP1 ATP0  1 e












Pulsatile application of ATPex (co-ordinated with pulsatile application of αA)
31[Seq.C10]
ATP_rise ATP0 ATP1 t  ATP0 ATP1 ATP0  1 e


















κatp2 t pulse_start t( ) Δτpulse_on 

ATP_pulse ATP0 ATP1 t  ATP ATP_rise ATP0 ATP1 t  τpulse_init t tcycles_end 0 t pulse_start t( ) Δτpulse_on if




Change in concentration of βA from βA0 to βA1 and its return to βA0.
βA βA0 βA1 t  βA0 0 t τβA1if
βA0 βA1 βA0  1 e







 τβA1 t τβA2if
βA0 βA1 βA0  1 e







 τβA2 t τβA3if
βA0 βA1 βA0  1 e












Change in intravascular pressure, BP, from BP0 to BP1 and its return to BP0.
32BP BP0 BP1 t  BP0 0 t τbp1if
BP0 BP1 BP0  1 e







 τbp1 t τbp2if
BP0 BP1 BP0  1 e







 τbp2 t τbp3if
BP0 BP1 BP0  1 e












Change in concentration of EET from EET0 to EET1 and its return to EET0.
EET EET0 EET1 t  EET0 0 t τeet1if
EET0 EET1 EET0  1 e







 τeet1 t τeet2if
EET0 EET1 EET0  1 e







 τeet2 t τeet3if
EET0 EET1 EET0  1 e












Change in concentration of NO from NO0 to NO1 and its return to NO0.
NO NO0 NO1 t  NO0 0 t τno1if
NO0 NO1 NO0  1 e







 τno1 t τno2if
NO0 NO1 NO0  1 e







 τno2 t τno3if
NO0 NO1 NO0  1 e












D. DIFFUSION OF Ca BETWEEN COMPARTMENTS
33In the steady-state equations below, the variable c = Cain is the uniform concentration of Ca in the cytoplasm.
Total flux of Ca between all junctions and the cytoplasm
[Seq.D1] Jjun_cyt Cajun c  109 λjun_cyt Cajun c  (fmol/(s*cell) ; conc in μM)
Total flux between total central SR and  peripheral SR
[Seq.D2] Jcen_per CaSRcen CaSRper  109 λcen_per CaSRcen CaSRper 
Total flux between NSCstr micordomains and the cytoplasm
[Seq.D3] JCaNSCstr_cyt CaNSC_str c  109 λNSCstr_cyt CaNSC_str c 
E. SARCOLEMMAL CHANNELS OPEN PROBABILITIES, FLUXES, AND CURRENTS 
Fluxes  into the cytoplasm from the extracellular medium or from intracellular compartments are taken as positive; positive currents  away 
 from the cytoplasm to the extracellular medium or to intracellular compartments are taken as positive. Fluxes between intracellular compartments
are also expressed as currents for comparison of their magnitudes with currents across the plasma membrane.
BK CHANNELS
Open probability of BK 


















1 exp zBK_J β v VBK_closed   
1 exp zBK_J β v VBK_open   

PBK v c( )
1
1 XBK v( )











 exp zBK_L β v 

[Seq.E3]
BK flux and current
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JBK v c Kin  J 109 BKT permBK PBK v c( ) Kex Kin  v 0=if
J 109 BKT permBK PBK v c( ) zK β v
Kex Kin exp zK β v  
exp zK β v  1 
 v 0if
[Seq.E4]  (fmol/(cell*s)).
 (pA/cell)[Seq.E5] IBK v c Kin 
zK F JBK v c Kin 
1000

Open probability  of BK phosphorylated by PKA (BKPKA) 
The enhancement is assumed to be due to an increase in LBK, now LBK_PKA.
PBK_PKA v c( )
1
1 XBK v( )











 exp zBK_L β v 

[Seq.E6]
BK_PKA flux and current
JBK_PKA v c Kin  J 109 BKT permBK PBK_PKA v c( ) Kex Kin  v 0=if
J 109 BKT permBK PBK_PKA v c( ) zK β v
Kex Kin exp zK β v  




IBK_PKA v c Kin 
zK F JBK_PKA v c Kin 
1000
[Seq.E8]
Open probability of BK phosphorylated by PKC (BKPKC) 
The suppression is assumed to be due to a decrease in LBK, now LBK_PKC.
PBK_PKC v c( )
1
1 XBK v( )











 exp zBK_L β v 
[Seq.E9]
BK_PKC flux and current
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JBK_PKC v c Kin  J 109 BKT permBK PBK_PKC v c( ) Kex Kin  v 0=if
J 109 BKT permBK PBK_PKC v c( ) zK β v
Kex Kin exp zK β v  




[Seq.E11] IBK_PKC v c Kin 
zK F JBK_PKC v c Kin 
1000

Open probability of BK phosphorylated by PKG (BKPKG) 
The enhancement is assumed to be due to an increase in LBK, now LBK_PKG.
PBK_PKG v c( )
1
1 XBK v( )











 exp zBK_L β v 
[Seq.E12]
BK_PKG flux and current
JBK_PKG v c Kin  J 109 BKT permBK PBK_PKG v c( ) Kex Kin  v 0=if
J 109 BKT permBK PBK_PKG v c( ) zK β v
Kex Kin exp zK β v  





IBK_PKG v c Kin 
zK F JBK_PKG v c Kin 
1000

Total flux and current due to  BK and PKA-, PKG- and  PKC-phosphorylated BK
[Seq.E15] IBK_ALL v c Kin BK BKPKA BKPKC BKPKG 
1
BKT
BK IBK v c Kin  BKPKC IBK_PKC v c Kin 








[Seq.E16] JBK_ALL v c Kin BK BKPKA BKPKC BKPKG 
1000
F
IBK_ALL v c Kin BK BKPKA BKPKC BKPKG 
CaV CHANNELS





















[Seq.E19] PCaV v c( ) XCaVa v( ) YCaVi v c( )
CaV flux and current
JCaV v c( ) J 10
6 CaVT permCaV PCaV v c( ) Caex c  v 0=if
J 106 CaVT permCaV PCaV v c( ) zCa β v
Caex c exp zCa β v  




[Seq.E21] ICaV v c( )
zCa F JCaV v c( )
1000
















[Seq.E23] PCaV_PKC v c( ) XCaV_PKC_a v( ) YCaVi v c( )
CaVPKC flux and current
JCaV_PKC v c( ) J 10
6 CaVT permCaV PCaV_PKC v c( ) Caex c  v 0=if
J 106 CaVT permCaV PCaV_PKC v c( ) zCa β v
Caex c exp zCa β v  




[Seq.E25] ICaV_PKC v c( )



















PCaV_PKG v c( ) XCaV_PKG_a v( ) YCaVi v c( )[Seq.E27]
CaVPKG flux and current
JCaV_PKG v c( ) J 10
6 CaVT permCaV PCaV_PKG v c( ) Caex c  v 0=if
J 106 CaVT permCaV PCaV_PKG v c( ) zCa β v
Caex c exp zCa β v  




[Seq.E29] ICaV_PKG v c( )
zCa F JCaV_PKG v c( )
1000

Total current due to CaV + CaV.PKC  + CaVPKG
[Seq.E30] ICaV_ALL v c CaV CaVPKC CaVPKG 




Open probability of ClA
38Assume that KClA_Ca_act decreases with V with an effective moving charge of ζClA..
XClA v( )
1











































ClA flux and current
[Seq.E34] ξCl v Clin  zCl β v
Clex Clin exp zCl β v  
exp zCl β v  1

JClA v CaNSC_str Clin  J 109 ClAT permClA PClA v CaNSC_str  Clex Clin  v 0=if
J 109 ClAT permClA PClA v CaNSC_str  ξCl v Clin  v 0if
[Seq.E35]
[Seq.E36] IClA v CaNSC_str Clin 






KATP flux &  current
JKATP v Kin KATP  J 109 KATP permKATP Popen_KATP Kex Kin  v 0=if
J 109 KATP permKATP Popen_KATP zK β v
Kex Kin exp zK β v  




[Seq.E38] IKATP v Kin KATP 
zK F JKATP v Kin KATP 
1000

KATP_PKA flux &  current
JKATP_PKA v Kin KATPPKA  J 109 KATPPKA permKATP Popen_KATP_PKA Kex Kin  v 0=if
J 109 KATPPKA permKATP Popen_KATP_PKA zK β v
Kex Kin exp zK β v  




[Seq.E40] IKATP_PKA v Kin KATPPKA 
zK F JKATP_PKA v Kin KATPPKA 
1000

KATP_ALL flux &  current
JKATP_ALL v Kin KATP KATPPKA  JKATP v Kin KATP  JKATP_PKA v Kin KATPPKA [Seq.E41]
















Kv flux & current
JKv v Kin  J 109 KvT permKv PKv v( ) Kex Kin  v 0=if
J 109 KvT permKv PKv v( ) zK β v
Kex Kin exp zK β v  




[Seq.E45] IKv v Kin 




Cl leak flux & current
JCl_leak v Clin  J 109 ClleakT permCl_leak Clex Clin  v 0=if
J 109 ClleakT permCl_leak zCl β v
Clex Clin exp zCl β v  





ICl_leak v Clin 
zCl F JCl_leak v Clin 
1000

K leak flux & current
JK_leak v Kin  J 109 KleakT permK_leak Kex Kin  v 0=if
J 109 KleakT permK_leak zK β v
Kex Kin exp zK β v  





[Seq.E49] IK_leak v Kin 
zK F JK_leak v Kin 
1000

Na leak flux & current
JNa_leak v Nain  J 109 NaleakT permNa_leak Naex Nain  v 0=if
J 109NaleakT permNa_leak zNa β v
Naex Nain exp zNa β v  




[Seq.E51] INa_leak v Nain 
zNa F JNa_leak v Nain 
1000

Ca leak flux & current
[Seq.E52] JCa_leak v Cain  J 106 CaleakT permCa_leak Caex Cain   v 0=if
J 106CaleakT permCa_leak zCa β v
Caex Cain exp zCa β v  
exp zCa β v  1
 v 0if

[Seq.E53] ICa_leak v Cain 




[Seq.E54] IALL_leak v Kin Nain Clin Cain  IK_leak v Kin  INa_leak v Nain  ICl_leak v Clin  ICa_leak v Cain 
NSCeet CHANNELS
Open probability of NSCeet channels 
42










PNSCeet v eet( )
1
1 exp


















NSCeet fluxes and currents NSCeet
JNaNSCeet v eet Nain  J 109 NSCeetT permNaNSCeet PNSCeet v eet( ) Naex Nain  v 0=if
J 109 NSCeetT permNaNSCeet PNSCeet v eet( ) zNa β v
Naex Nain exp zNa β v  





INaNSCeet v eet Nain 
zNa F JNaNSCeet v eet Nain 
1000

[Seq.E59] JKNSCeet v eet Kin  J 109 NSCeetT permKNSCeet PNSCeet v eet( ) Kex Kin  v 0=if
J 109 NSCeetT permKNSCeet PNSCeet v eet( ) zK β v
Kex Kin exp zK β v  




IKNSCeet v eet Kin 
zK F JKNSCeet v eet Kin 
1000

JCaNSCeet v eet cajun  J 106 NSCeetT permCaNSCeet PNSCeet v eet( ) Caex cajun  v 0=if
J 106 NSCeetT permCaNSCeet PNSCeet v eet( ) zCa β v
Caex cajun exp zCa β v  





[Seq.E62] ICaNSCeet v eet cajun 
zCa F JCaNSCeet v eet cajun 
1000

[Seq.E63] INSCeet_ALL v eet Nain Kin cajun  INaNSCeet v eet Nain  IKNSCeet v eet Kin  ICaNSCeet v eet cajun 
NSCne CHANNELS 
Open probability of NSCne channels 










































NSCne fluxes & currents
JNaNSCne v DAG Nain c  J 109 NSCneT permNaNSCne PNSCne DAG c( ) Naex Nain  v 0=if
J 109 NSCneT permNaNSCne PNSCne DAG c( ) zNa β v
Naex Nain exp zNa β v  




[Seq.E66] INaNSCne v DAG Nain c 
zNa F JNaNSCne v DAG Nain c 
1000

JKNSCne v DAG Kin c  J 109 NSCneT permKNSCne PNSCne DAG c( ) Kex Kin  v 0=if
J 109 NSCneT permKNSCne PNSCne DAG c( ) zK β v
Kex Kin exp zK β v  





[Seq.E68] IKNSCne v DAG Kin c 
zK F JKNSCne v DAG Kin c 
1000

JCaNSCne v DAG c( ) J 10
6 NSCneT permCaNSCne PNSCne DAG c( ) Caex c  v 0=if
J 106 NSCneT permCaNSCne PNSCne DAG c( ) zCa β v
Caex c exp zCa β v  




[Seq.E70] ICaNSCne v DAG c( )
zCa F JCaNSCne v DAG c( )
1000

[Seq.E71] INSCne_ALL v DAG Nain Kin c  INaNSCne v DAG Nain c  IKNSCne v DAG Kin c  ICaNSCne v DAG c( )
NSCstr CHANNELS
Open probability for NSCstr channels 









































































































PNSCstr DAG CaNSC_str bp  SNSCstr_act DAG bp( ) XNSCstr_act CaNSC_str  YNSCstr_inh CaNSC_str [Seq.E77]
[Seq.E78] PNSCstr_PKC DAG CaNSC_str bp  SNSCstr_act DAG bp( ) XNSCstr_PKC_act CaNSC_str  YNSCstr_inh CaNSC_str 
[Seq.E79] PNSCstr_PKG DAG CaNSC_str bp  SNSCstr_act DAG bp( ) XNSCstr_PKG_act CaNSC_str  YNSCstr_inh CaNSC_str 
NSCstr Na+ flux and current
[Seq.E80] ξNa v Nain  zNa β v
Naex Nain exp zNa β v  
exp zNa β v  1 

JNaNSCstr v DAG Nain CaNSC_str bp NSCstr  J 109 NSCstr permNaNSCstr PNSCstr DAG CaNSC_str bp  Naex Nain  v 0=if




JNaNSCstr_PKC v DAG Nain CaNSC_str bp NSCstr_PKC  J 109 NSCstr_PKC permNaNSCstr PNSCstr_PKC DAG CaNSC_str bp  Naex Nain  v 0=if




JNaNSCstr_PKG v DAG Nain CaNSC_str bp NSCstr_PKG  J 109 NSCstr_PKG permNaNSCstr PNSCstr_PKG DAG CaNSC_str bp  Naex Nain  v 0=if
J 109 NSCstr_PKG permNaNSCstr PNSCstr_PKG DAG CaNSC_str bp  ξNa v Nain  v 0if

[Seq.E84] INaNSCstr v DAG Nain CaNSC_str bp NSCstr 
zNa F JNaNSCstr v DAG Nain CaNSC_str bp NSCstr 
1000

[Seq.E85] INaNSCstr_PKC v DAG Nain CaNSC_str bp NSCstr_PKC 
zNa F JNaNSCstr_PKC v DAG Nain CaNSC_str bp NSCstr_PKC 
1000

[Seq.E86] INaNSCstr_PKG v DAG Nain CaNSC_str bp NSCstr_PKG 
zNa F JNaNSCstr_PKG v DAG Nain CaNSC_str bp NSCstr_PKG 
1000

INaNSCstr_ALL v DAG Nain CaNSC_str bp NSCstr NSCstr_PKC NSCstr_PKG  INaNSCstr v DAG Nain CaNSC_str bp NSCstr 
INaNSCstr_PKC v DAG Nain CaNSC_str bp NSCstr_PKC 





 NSCstr K+ flux and current
[Seq.E88] ξK v Kin  zK β v
Kex Kin exp zK β v  
exp zK β v  1 

JKNSCstr v DAG Kin CaNSC_str bp NSCstr  J 109 NSCstr permKNSCstr PNSCstr DAG CaNSC_str bp  Kex Kin  v 0=if




JKNSCstr_PKC v DAG Kin CaNSC_str bp NSCstr_PKC  J 109 NSCstr_PKC permKNSCstr PNSCstr_PKC DAG CaNSC_str bp  Kex Kin  v 0=if




JKNSCstr_PKG v DAG Kin CaNSC_str bp NSCstr_PKG  J 109 NSCstr_PKG permKNSCstr PNSCstr_PKG DAG CaNSC_str bp  Kex Kin  v 0=if
J 109 NSCstr_PKG permKNSCstr PNSCstr_PKG DAG CaNSC_str bp  ξK v Kin  v 0if

[Seq.E92] IKNSCstr v DAG Kin CaNSC_str bp NSCstr 
zK F JKNSCstr v DAG Kin CaNSC_str bp NSCstr 
1000

[Seq.E93] IKNSCstr_PKC v DAG Kin CaNSC_str bp NSCstr_PKC 
zK F JKNSCstr_PKC v DAG Kin CaNSC_str bp NSCstr_PKC 
1000

[Seq.E94] IKNSCstr_PKG v DAG Kin CaNSC_str bp NSCstr_PKG 
zK F JKNSCstr_PKG v DAG Kin CaNSC_str bp NSCstr_PKG 
1000

IKNSCstr_ALL v DAG Kin CaNSC_str bp NSCstr NSCstr_PKC NSCstr_PKG  IKNSCstr v DAG Kin CaNSC_str bp NSCstr 
IKNSCstr_PKC v DAG Kin CaNSC_str bp NSCstr_PKC 





NSCstr Ca2+ flux and current
[Seq.E96] ξCa v CaNSC_str  zCa β v
Caex CaNSC_str exp zCa β v  
exp zCa β v  1 

JCaNSCstr v DAG CaNSC_str bp NSCstr  J 106 NSCstr permCaNSCstr PNSCstr DAG CaNSC_str bp  Caex CaNSC_str  v 0=if





JCaNSCstr_PKC v DAG CaNSC_str bp NSCstr_PKC  J 106 NSCstr_PKC permCaNSCstr PNSCstr_PKC DAG CaNSC_str bp  Caex CaNSC_str  v 0=if
J 106 NSCstr_PKC permCaNSCstr PNSCstr_PKC DAG CaNSC_str bp  ξCa v CaNSC_str  v 0if

[Seq.E99]
JCaNSCstr_PKG v DAG CaNSC_str bp NSCstr_PKG  J 106 NSCstr_PKG permCaNSCstr PNSCstr_PKG DAG CaNSC_str bp  Caex CaNSC_str  v 0=if
J 106 NSCstr_PKG permCaNSCstr PNSCstr_PKG DAG CaNSC_str bp  ξCa v CaNSC_str  v 0if

JCaNSCstr_ALL v DAG CaNSC_str bp NSCstr NSCstr_PKC NSCstr_PKG  JCaNSCstr v DAG CaNSC_str bp NSCstr 
JCaNSCstr_PKC v DAG CaNSC_str bp NSCstr_PKC 





[Seq.E101] ICaNSCstr v DAG CaNSC_str bp NSCstr 
zCa F JCaNSCstr v DAG CaNSC_str bp NSCstr 
1000

[Seq.E102] ICaNSCstr_PKC v DAG CaNSC_str bp NSCstr_PKC 
zCa F JCaNSCstr_PKC v DAG CaNSC_str bp NSCstr_PKC 
1000

[Seq.E103] ICaNSCstr_PKG v DAG CaNSC_str bp NSCstr_PKG 
zCa F JCaNSCstr_PKG v DAG CaNSC_str bp NSCstr_PKG 
1000

ICaNSCstr_ALL v DAG CaNSC_str bp NSCstr NSCstr_PKC NSCstr_PKG  ICaNSCstr v DAG CaNSC_str bp NSCstr 
ICaNSCstr_PKC v DAG CaNSC_str bp NSCstr_PKC 





NSCstr Na+ + K+ + Ca2+ currents 
[Seq.E105]
INSCstr_ALL v DAG Nain Kin CaNSC_str bp NSCstr NSCstr_PKC NSCstr_PKG  INaNSCstr_ALL v DAG Nain CaNSC_str bp NSCstr NSCstr_PKC NSCstr_PKG 
IKNSCstr_ALL v DAG Kin CaNSC_str bp NSCstr NSCstr_PKC NSCstr_PKG 






P2X1R fluxes & currents
JNaP2XR v Nain P2XR_3_act  J 109 P2XR_3_act permNaP2XR Naex Nain  v 0=if
J 109 P2XR_3_act permNaP2XR zNa β v
Naex Nain exp zNa β v  




[Seq.E107] INaP2XR v Nain P2XR_3_act 
zNa F JNaP2XR v Nain P2XR_3_act 
1000

JKP2XR v Kin P2XR_3_act  J 109 P2XR_3_act permKP2XR Kex Kin  v 0=if
J 109 P2XR_3_act permKP2XR zK β v
Kex Kin exp zK β v  




[Seq.E109] IKP2XR v Kin P2XR_3_act 
zK F JKP2XR v Kin P2XR_3_act 
1000

JCaP2XR v c P2XR_3_act( ) J 10
6 P2XR_3_act permCaP2XR Caex c  v 0=if
J 106 P2XR_3_act permCaP2XR zCa β v
Caex c exp zCa β v  




[Seq.E111] ICaP2XR v c P2XR_3_act( )
zCa F JCaP2XR v c P2XR_3_act( )
1000

[Seq.E112] IP2XR_ALL v Nain Kin c P2XR_3_act  INaP2XR v Nain P2XR_3_act  IKP2XR v Kin P2XR_3_act  ICaP2XR v c P2XR_3_act( )
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F. SR CHANNELS OPEN PROBABILITIES, FLUXES, AND CURRENTS
IP3R
Binding of IP3 to IP3R and to IP3R_IRAG_PKG



































































Ca binding to SR lumenal activation site








IP3R and IP3R_IRAG_PKG open probabilities




nIP3R_Ca_act KIP3R_Ca_act IP3( )
nIP3R_Ca_act

YIP3_Ca_inh c( ) ZIP3R_CaSR CaSRcen 




nIP3R_Ca_act KIP3R_IRAG_PKG_Ca_act IP3( )
nIP3R_Ca_act

YIP3_Ca_inh c( ) ZIP3R_CaSR CaSRcen [Seq.F8]
Flux & currents  via IP3R & IP3R_IRAG_PKG
[Seq.F9] JIP3R c IP3 CaSRcen IP3R  106 IP3R permIP3R PIP3R c IP3 CaSRcen  CaSRcen c 
[Seq.F10] JIP3R_IRAG_PKG c IP3 CaSRcen IP3RIRAG_PKG  106 IP3RIRAG_PKG permIP3R PIP3R_IRAG_PKG c IP3 CaSRcen  CaSRcen c 
[Seq.F11] JIP3R_ALL c IP3 CaSRcen IP3R IP3RIRAG_PKG  JIP3R c IP3 CaSRcen IP3R  JIP3R_IRAG_PKG c IP3 CaSRcen IP3RIRAG_PKG 
[Seq.F12] IIP3R_ALL c IP3 CaSRcen IP3R IP3RIRAG_PKG 
zCa F
1000
 JIP3R_ALL c IP3 CaSRcen IP3R IP3RIRAG_PKG 
RyR
52Ca binding to sensitizing sites facing peripheral SR lumen increases afffinity of junctional sites.























































[Seq.F18] fRyR_PKA RyRPKA  1 1 fRyR_PKA_min  ZRyR_PKA RyRPKA 2
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[Seq.F21] fRyR_PKC RyRPKC  1 1 fRyR_PKC_max  ZRyR_PKC RyRPKC 2








RyR flux into junction
[Seq.F23]
JRyR Cajun CaSRper RyRPKA RyRPKC  106 1 ZRyR_PKA RyRPKA  ZRyR_PKC RyRPKC   RyRT permRyR PRyR Cajun CaSRper  CaSRper Cajun 
RyRPKA flux into junction
[Seq.F24] JRyR_PKA Cajun CaSRper RyRPKA  106 ZRyR_PKA RyRPKA  RyRT permRyR PRyR_PKA Cajun CaSRper RyRPKA  CaSRper Cajun 
RyRPKC flux into junction
54
JRyR_PKC Cajun CaSRper RyRPKC  106 ZRyR_PKC RyRPKC  RyRT permRyR PRyR_PKC Cajun CaSRper RyRPKC  CaSRper Cajun [Seq.F25]
RyR + RyRPKA + RyRPKC flux into junction
JRyR_ALL Cajun CaSRper RyRPKA RyRPKC  JRyR Cajun CaSRper RyRPKA RyRPKC  JRyR_PKA Cajun CaSRper RyRPKA 
JRyR_PKC Cajun CaSRper RyRPKC 
[Seq.F26]
RyR + RyRPKA + RyRPKC current
[Seq.F27] IRyR_ALL Cajun CaSRper RyRPKA RyRPKC 
zCa F
1000




relΔμNaK v Nain Kin 


























































 relΔμNaK v Nain Kin 
NaKCl cotransporter






























































[Seq.G7] J4_NaKCl NaKCl Nain Kin Clin 
NaKCl
D1 Q Nain Kin Clin  D2 Nain Kin Clin  
αNaKCl_4 βNaKCl_4 Q Nain Kin Clin  
[Seq.G8] J4_NaKCl_PKC NaKClPKC Nain Kin Clin 
εNaKCl_PKC NaKClPKC
D1 Q Nain Kin Clin  D2 Nain Kin Clin  
αNaKCl_4 βNaKCl_4 Q Nain Kin Clin  
[Seq.G9]
J4_NaKCl_ALL NaKCl NaKClPKC Nain Kin Clin  J4_NaKCl NaKCl Nain Kin Clin  J4_NaKCl_PKC NaKClPKC Nain Kin Clin 
Cl flux
56
[Seq.G10] JNaK_Cl NaKCl NaKClPKC Nain Kin Clin 
2 1015
NA
J4_NaKCl_ALL NaKCl NaKClPKC Nain Kin Clin 
Na flux
[Seq.G11] JKCl_Na NaKCl NaKClPKC Nain Kin Clin 
1015
NA
J4_NaKCl_ALL NaKCl NaKClPKC Nain Kin Clin 
K flux
[Seq.G12] JNaCl_K NaKCl NaKClPKC Nain Kin Clin 
1015
NA
J4_NaKCl_ALL NaKCl NaKClPKC Nain Kin Clin 
Cl current (currents of Na,K, & Cl add to zero)
[Seq.G13] INaK_Cl NaKCl NaKClPKC Nain Kin Clin 
zCl F
1000
JNaK_Cl NaKCl NaKClPKC Nain Kin Clin 
NCX 
Microscopic reversibility applied to binding and isomerizations at Vm =0, assuming that the Na affinities and the Ca
























































































Net isomerization rate of transporter from 3 Na out and 1 Ca in to 3 Na in and 1 Ca out
[Seq.G19] S4 v Cain Nain  αNCX_4 QQ v Cain Nain  βNCX_4 
ZNCX_act Cain  NCXT




INCX v Cain Nain 
1012 F
NA
S4 v Cain Nain 
Plasma Membrane CaATPase
Relative free energy difference
58
[Seq.G21]






























 relΔμPMCA v c( )
SERCA
Relative activities of SERCA and phosphorylated SERCA




























































SERCA & SERCA_P fluxes & current
2 Ca2+ countered by 2 H+ per ATP
gives 2 net charges transported per cycle
or 1 Ca2+ per charge transported.
[Seq.G25]













[Seq.G26] JSERCA c CaSRcen 
1 103
F
ISERCA_max relSERCA c CaSRcen  relΔμSERCA c CaSRcen 
[Seq.G27] JSERCA_P c CaSRcen 
1 103
F
ISERCA_max relSERCA_P c CaSRcen  relΔμSERCA c CaSRcen 
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[Seq.G28] JSERCA_ALL c CaSRcen SERCA SERCA_P 
SERCA JSERCA c CaSRcen  SERCA_P JSERCA_P c CaSRcen 
SERCAT

[Seq.G29] ISERCA_ALL c CaSRcen SERCA SERCA_P 
F
1000
 JSERCA_ALL c CaSRcen SERCA SERCA_P 
H. ENZYMES
PHOSPHODIESTERASES (PDE)
Active fraction of cAMP-specific PDE








Active fraction of phosphorylated cAMP-specific PDE








Active fraction of cGMP-specific PDE








Active fraction of phosphorylated cGMP-specific PDE



















Active fraction of PKC
























Active fraction of PKCε










Active fraction of PKD


























kGC_act_GTP GC1_act t( ) kGC_basal_GTP GCT GC1_act t( ) 












kGC0_NO_on  GC0 t( ) NO NO0 NO1 t  kGC1_NO_off GC1 t( ) kGC1_act GC1 t( )













kGC1_act GC1 t( ) kGC1_deact GC1_act t( ) kGC2_act GC2 t( ) kPKG_GC relPKG1 cGMP t( )( ) GC1_act t( )=






























kαAR_on αA_steady αA0 αA1 t  αAR0 t( ) kαAR_off kGq0_GDP_αAR_on Gq0_GDP t( ) kαAR_P  αAR1 t( )


















kGq1_GDP_GTP_exch Gq1_GDP t( ) kGq_GTPase Gq0_GTP t( ) kPLC_Gq0_GTP_on Gq0_GTP t( ) PLC t( )


















kPLC_Gq0_GTP_on PLC t( ) Gq0_GTP t( ) kPLC_Gq0_GTP_off PLCGq0_GTP t( ) kPLC_Gq0_GTP_hyd PLCGq0_GTP t( )
kPLC_Gq0_GTP_PIP_on PLCGq0_GTP t( ) PIPT  kPLC_Gq0_GTP_PIP_off PLCGq0_GTP_PIP t( )

kPLC_Gq0_GTP_PIP_hyd PLCGq0_GTP_PIP t( ) kPKA_PLC_Gq0_GTP relPKA1 cAMP t( )( ) PLCGq0_GTP t( ) 










kPLC_Gq0_GTP_PIP_on PLCGq0_GTP t( ) PIPT kPLC_Gq0_GTP_PIP_off PLCGq0_GTP_PIP t( )






kPKA_PLC_Gq0_GTP relPKA1 cAMP t( )( ) kPKC_PLC_Gq0_GTP relPKC11 DAG t( ) Cain t( )   PLCGq0_GTP t( )

































kPKG_BK relPKG1 cGMP t( )( ) BK t( ) kPP_BK BKPKG t( )=
[Seq.J25] αAR0 t( ) αAR1 t( ) αARP t( ) αARin t( ) Gq1_GDP t( ) αART=
Gq0_GDP t( ) Gq0_GTP t( ) Gq1_GDP t( ) PLCGq0_GTP t( ) PLCGq0_GTP_PIP t( ) PLCP_Gq0_GTP t( ) GqT=[Seq.J26]
[Seq.J27] BK t( ) BKPKC t( ) BKPKA t( ) BKPKG t( ) BKT=














IP2XR_ALL V t( ) Nain t( ) Kin t( ) Cain t( ) P2XR_3_act t( )  IKATP_ALL V t( ) Kin t( ) KATP t( ) KATPPKA t( ) 
INSCne_ALL V t( ) DAG t( ) Nain t( ) Kin t( ) Cain t( )  IBK_ALL V t( ) Cajun t( ) Kin t( ) BK t( ) BKPKA t( ) BKPKC t( ) BKPKG t( ) 

ICaV_ALL V t( ) Cain t( ) CaV t( ) CaVPKC t( ) CaVPKG t( )  IKv V t( ) Kin t( )  IPMCA V t( ) Cain t( )  INCX V t( ) Cain t( ) Nain t( ) 

INaK V t( ) Nain t( ) Kin t( ) 

INSCstr_ALL V t( ) DAG t( ) Nain t( ) Kin t( ) CaNSCstr t( ) BP BP0 BP1 t  NSCstr t( ) NSCstr_PKC t( ) NSCstr_PKG t( ) 

IClA V t( ) CaNSCstr t( ) Clin t( ) 

































IClA V t( ) CaNSCstr t( ) Clin t( )  ICl_leak V t( ) Clin t( )  
10 12
VOLcell

































INaP2XR V t( ) Nain t( ) P2XR_3_act t( )  INaNSCne V t( ) DAG t( ) Nain t( ) Cain t( ) 
INaNSCstr_ALL V t( ) DAG t( ) Nain t( ) CaNSCstr t( ) BP BP0 BP1 t  NSCstr t( ) NSCstr_PKC t( ) NSCstr_PKG t( ) 

3 INCX V t( ) Cain t( ) Nain t( )  3 INaK V t( ) Nain t( ) Kin t( )  INaNSCeet V t( ) EET EET0 EET1 t  Nain t( ) 
























IKP2XR V t( ) Kin t( ) P2XR_3_act t( )  IKATP_ALL V t( ) Kin t( ) KATP t( ) KATPPKA t( ) 
IBK_ALL V t( ) Cajun t( ) Kin t( ) BK t( ) BKPKA t( ) BKPKC t( ) BKPKG t( ) 

IKNSCne V t( ) DAG t( ) Kin t( ) Cain t( ) 

IKNSCstr_ALL V t( ) DAG t( ) Kin t( ) CaNSCstr t( ) BP BP0 BP1 t  NSCstr t( ) NSCstr_PKC t( ) NSCstr_PKG t( ) 




























ICaP2XR V t( ) Cain t( ) P2XR_3_act t( )  ICaV_ALL V t( ) Cain t( ) CaV t( ) CaVPKC t( ) CaVPKG t( )  
10 6
zCa F VOLcell








IPMCA V t( ) Cain t( )  INCX V t( ) Cain t( ) Nain t( )  
10 9
VOLcell








JIP3R_ALL Cain t( ) IP3 t( ) CaSRcen t( ) IP3R t( ) IP3RIRAG_PKG t( ) 
10 9
VOLcell











JRyR_ALL Cajun t( ) CaSRper t( ) RyRPKA t( ) RyRPKC t( ) 
10 9
VOLjun
Jjun_cyt Cajun t( ) Cain t( ) 















JRyR_ALL Cajun t( ) CaSRper t( ) RyRPKA t( ) RyRPKC t( )  Jcen_per CaSRcen t( ) CaSRper t( )  









JSERCA_ALL Cain t( ) CaSRcen t( ) SERCA t( ) SERCA_P t( )  Jcen_per CaSRcen t( ) CaSRper t( )  














kβAR_on βA βA0 βA1 t  βAR0 t( ) kβAR_off kGs0_GDP_βAR_on Gs0_GDP t( ) kβAR_P  βAR1 t( )














kβAR_P βAR1 t( ) kβAR_endo βARP t( )=












kGs0_GDP_βAR_on Gs0_GDP t( ) βAR1 t( ) kGs1_GDP_βAR_off Gs1_GDP t( ) kGs1_GDP_GTP_exch Gs1_GDP t( )=
[Seq.J48] Gs0_GDP t( ) Gs0_GTP t( ) Gs1_GDP t( ) AC1 t( ) GsT=






kPKG_IP3R_IRAG relPKG1 cGMP t( )( ) IP3R t( ) kPP_IP3R_IRAG_PKG IP3RIRAG_PKG t( )=







JCaNSCstr_ALL V t( ) DAG t( ) CaNSCstr t( ) BP BP0 BP1 t  NSCstr t( ) NSCstr_PKC t( ) NSCstr_PKG t( ) 


























kPKC_RyR relPKC11 DAG t( ) Cajun t( )  RyR t( ) kPP_RyR RyRPKC t( )=












kPKG_CaV relPKG1 cGMP t( )( ) CaV t( ) kPP_CaV CaVPKG t( )=




kPKA_SERCA relPKA1 cAMP t( )( ) kPKG_SERCA relPKG1 cGMP t( )( ) kPKC_SERCA relPKC11 DAG t( ) Cain t( )   SERCA t( )
kPP_SERCA SERCA_P t( ) 
=[Seq.J60]
68






kPKA_PDE relPKA1 cAMP t( )( ) kPKG_PDE relPKG1 cGMP t( )( )  PDEcAMP t( ) kPP_PDE PDEcAMP_P t( )=






kPKA_PDE relPKA1 cAMP t( )( ) kPKG_PDE relPKG1 cGMP t( )( )  PDEcGMP t( ) kPP_PDE PDEcGMP_P t( )=
[Seq.J65] PDEcGMP t( ) PDEcGMP_P t( ) PDEcGMP_T=






kPKC_NaKCl relPKC11 DAG t( ) Cain t( )  NaKCl t( ) kPP_NaKCl
PPNaKCl t( )
PPNaKCl_T
 NaKClPKC t( ) kPP_P_NaKCl
PPP_NaKCl t( )
PPNaKCl_T
 NaKClPKC t( )=










kPKG_NSCstr relPKG1 cGMP t( )( ) NSCstr t( ) kPP_NSCstr NSCstr_PKG t( )=
[Seq.J72] NSCstr t( ) NSCstr_PKC t( ) NSCstr_PKG t( ) NSCstrT=



















kPKCε_KATP relPKCεDAG DAG t( )( ) KATP t( ) kPP_KATP_PKCε KATPPKCε t( )=




kP2XR_0_on ATP_steady ATP0 αA1 t n_P2XR P2XR_0 t( ) kP2XR_3_off P2XR_3 t( ) kP2XR_3_act P2XR_3 t( )










kP2XR_0_desens P2XR_0 t( ) kP2XD_0_resens P2XD_0 t( )






kP2XR_3_act_desens P2XR_3_act t( ) kP2XD_3_resens P2XD_3 t( )





kP2XD_0_PKD_on ATP_steady ATP0 αA1 t n_P2XR P2XD_0_PKD t( )





kPKD_P2XD_3 relPKDDAG DAG t( )( ) P2XD_3 t( )
kP2XD_0_PKD_on ATP_steady ATP0 αA1 t n_P2XR P2XD_0_PKD t( ) kP2XD_3_PKD_off P2XD_3_PKD t( )
=[Seq.J82]
Initial conditions
[Seq.J83-89] βAR0 t0( ) βART= βAR1 t0( ) 0= βARP t0( ) 0= βARin t0( ) 0= Gs0_GDP t0( ) GsT= Gs0_GTP t0( ) 0= Gs1_GDP t0( ) 0=
70[Seq.J90-96] Gq0_GTP t0( ) 0= GC0 t0( ) GCT= GC1 t0( ) 0= GC2 t0( ) 0= GC1_act t0( ) 0= GC0P t0( ) 0= cGMP t0( ) 0=
[Seq.J97-103] αAR0 t0( ) αART= αAR1 t0( ) 0= αARP t0( ) 0= αARin t0( ) 0= Gq0_GDP t0( ) GqT= Gq1_GDP t0( ) 0= PLC t0( ) PLCT=
[Seq.J104-110] PLCGq0_GTP t0( ) 0= PLCGq0_GTP_PIP t0( ) 0= PLCPIP t0( ) 0= PLCP t0( ) 0= PLCP_Gq0_GTP t0( ) 0= IP3 t0( ) 0= DAG t0( ) 0=
[Seq.J111-117] AC1 t0( ) 0= AC0 t0( ) ACT= ACP t0( ) 0= cAMP t0( ) 0= PDEcGMP t0( ) PDEcGMP_T= PDEcGMP_P t0( ) 0= PDEcAMP t0( ) PDEcAMP_T=
[Seq.J118-123] PDEcAMP_P t0( ) 0= IP3R t0( ) IP3RT= IP3RIRAG_PKG t0( ) 0= NSCstr t0( ) NSCstrT= NSCstr_PKC t0( ) 0= NSCstr_PKG t0( ) 0=
[Seq.J124-130] BKPKC t0( ) 0= BKPKA t0( ) 0= BK t0( ) BKT= BKPKG t0( ) 0= RyRPKA t0( ) 0= RyRPKC t0( ) 0= RyR t0( ) RyRT=
[Seq.J131-136]
CaV t0( ) CaVT= CaVPKC t0( ) 0= CaVPKG t0( ) 0= SERCA t0( ) SERCAT= SERCA_P t0( ) 0= NaKCl t0( ) NaKClT=
[Seq.J137-143] NaKClPKC t0( ) 0= PPNaKCl t0( ) PPNaKCl_T= PPP_NaKCl t0( ) 0= V t0( ) 60= Nain t0( ) 7= Kin t0( ) 140= Cain t0( ) 0.1=
[Seq.J144-150] Clin t0( ) 50= Cajun t0( ) 0.1= CaSRper t0( ) 100= KATP t0( ) KATPT= KATPPKA t0( ) 0= KATPPKCε t0( ) 0= BUF1 t0( ) 2.6=
[Seq.J151-156] BUFjun1 t0( ) 2.6= BUFNSCstr1 t0( ) 2.6= CaSRcen t0( ) 100= CSQSRper1 t0( ) 33= CaNSCstr t0( ) 0.1= CSQSRcen1 t0( ) 33=




































































































































































































































































































































































































































































































































































































































Number of variables Vector of N1 +1 time points Number of effector concentrations 





p = each pressure or conc, in turn, of the varied effector.
Z is the vector of num_var functions of t for p = the ith+1 effector pressure or conc.
These functions are obtained by the call of W(p) to the solve block above. The kth+1
function is passed to F, which is evaluated at N1+1 times specified in the tt vector,
defined above. These values form the N1+1 rows of column k + i*num_var of
ALLDATA. In the present case, in which there are 81 functions of t returned by W(p)
and 6 values of p, ALLDATA consists of 12001 rows by 6*81 (=486) columns, such
that the first 81 columns correspond to the first value of p, the next 81 columns




Z W p( )
F Zk





k 0 num_var 1for


























Click on the table and use scroll bars to access the entire table.
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[Seq.J169] ALLDATA

















6E+003 0E+000 0E+000 0E+000
6E+003 0E+000 0E+000 0E+000
6E+003 0E+000 0E+000 0E+000
6E+003 0E+000 0E+000 0E+000
6E+003 0E+000 0E+000 0E+000
6E+003 0E+000 0E+000 0E+000
6E+003 0E+000 0E+000 0E+000
6E+003 0E+000 0E+000 0E+000
6E+003 0E+000 0E+000 0E+000
6E+003 0E+000 0E+000 0E+000
6E+003 0E+000 0E+000 0E+000
6E+003 0E+000 0E+000 0E+000
6E+003 0E+000 0E+000 0E+000
6E+003 0E+000 0E+000 0E+000
6E+003 0E+000 0E+000 0E+000
6E+003 0E+000 0E+000 ...

76ALLDATA6
TIME_POINTS submatrix ALLDATA 6 i 6 i 5 j j( )





j 0 num_eff_conc num_var 1for
M
ALLDATA6 is a compression in
which every 6 time points in
ALLDATA are averaged. It is
convenient for copying to Excel for
later processing and plotting.
[Seq.J170]
[Seq.J171] ALLDATA6

















6E+003 0E+000 0E+000 0E+000
6E+003 0E+000 0E+000 0E+000
6E+003 0E+000 0E+000 0E+000
6E+003 0E+000 0E+000 0E+000
6E+003 0E+000 0E+000 0E+000
6E+003 0E+000 0E+000 0E+000
6E+003 0E+000 0E+000 0E+000
6E+003 0E+000 0E+000 0E+000
6E+003 0E+000 0E+000 0E+000
6E+003 0E+000 0E+000 0E+000
6E+003 0E+000 0E+000 0E+000
6E+003 0E+000 0E+000 0E+000
6E+003 0E+000 0E+000 0E+000
6E+003 0E+000 0E+000 0E+000
6E+003 0E+000 0E+000 0E+000
6E+003 0E+000 0E+000 ...

77 K. EXTRACTING VARIABLES AS FUNCTIONS OF TIME FROM ALLDATA
To simplify defining plot variables, VARIABLE(k) is a submatrix of
ALLDATA corresponding to the variable with index k, as determined
by the order of variables in the vector following Odesolve above. The
first column of variable is the kth column of ALLDATA, which is
augmented, for all i, by the kth+ i*num_var column. In the current
case, for example, VARIABLE (14) corresponds to variable V and
consists of 6 columns, corresponding to the 6 values of BP1, and
N1+1 rows of V(t) values.These submatrices are assigned modified
names to distinguish them from the variables in the solve block.
[Seq.K1]
VARIABLE k( ) variable ALLDATA k
 

variable augment variable ALLDATA k i num_var
 
 
i 1 num_eff_conc 1for
variable

VARIABLE(k) for some k
[Seq.K2-6] VV VARIABLE 13( ) Ca_in VARIABLE 16( ) Ca_jun VARIABLE 31( ) Ca_NSCstr VARIABLE 60( ) Ca_SRcen VARIABLE 35( )
[Seq.K7-11] Ca_SRper VARIABLE 33( ) Na_in VARIABLE 14( ) K_in VARIABLE 15( ) Cl_in VARIABLE 18( ) NSC_str VARIABLE 66( )
[Seq.K12-15] NSC_str_PKC VARIABLE 67( ) NSC_str_PKG VARIABLE 68( ) Ca_V VARIABLE 26( ) Ca_V_PKC VARIABLE 27( )
[Seq.K16-20] Ca_V_PKG VARIABLE 28( ) BK VARIABLE 19( ) BK_PKA VARIABLE 20( ) BK_PKC VARIABLE 21( ) BK_PKG VARIABLE 22( )
[Seq.K21-25] RYR VARIABLE 23( ) RYR_PKA VARIABLE 24( ) RYR_PKC VARIABLE 25( ) SERCA VARIABLE 29( ) SERCA_P VARIABLE 30( )
[Seq.K26-30] DAG VARIABLE 12( ) IP_3 VARIABLE 11( ) c_AMP VARIABLE 53( ) c_GMP VARIABLE 42( ) IP3_R VARIABLE 58( )
[Seq.K31-35] IP3_R_PKG VARIABLE 59( ) αAR_0 VARIABLE 0( ) αAR_1 VARIABLE 1( ) αAR_p VARIABLE 2( ) αAR_in VARIABLE 3( )
[Seq.K36-39] Gq0_GTP VARIABLE 6( ) PLC_Gq0_GTP_PIP VARIABLE 9( ) P2X1R_0 VARIABLE 74( ) P2X1R_3 VARIABLE 75( )
[Seq.K40-43] P2X1R_3_act VARIABLE 76( ) P2X1D_0 VARIABLE 77( ) P2X1D_3 VARIABLE 78( ) P2X1D_0_PKD VARIABLE 79( )
[Seq.K44] P2X1D_3_PKD VARIABLE 80( )
78L. EFFECTOR CONCENTRATIONS & CURRENTS AS FUNCTIONS OF TIME
Currents that are functions of the above variables are tabulated such that the columns correspond to the different effector pressures or
concentrations and the rows are the values at N1+1 times. The currents are defined as steady-state equations above the solve block. In some
cases, the currents depend on effector concentrations. For each effector, a matrix with N1+1 rows and num_eff_conc columns is generated. For the
effector that is varied, the ith+1 column contains the concentrations at N1+1 times for the ith nominal concentration of the effector. For the other
effectors all colums are identrical.
Effector concentrations or pressures as functions of time
. 
i 0 num_eff_conc 1
[Seq.L1-3] αAAj i αA_steady αA0 alphaA1i ttj  βAAj i βA βA0 betaA1i ttj  B_Pressj i BP BP0 bp1i ttj 
[Seq.L4-6] EETTj i EET EET0 eet1i ttj  NOXj i NO NO0 nox1i ttj  ATPPj i ATP_steady ATP0 alphaA1i ttj 
Currents as functions of time
































































































































































M. PLOTS OF SOME VARIABLES AND FUNCTIONS OF VARIABLES VERSUS TIME
The column index <i> refers to the ith +1 intravascular pressure; e.g., <0> refers to 10 mm Hg, <1> to 20 mm Hg, etc.
[Splot M1-3]



















































































































































































































































































































































































































































































































































































































































































































































































































































































































































N. MEANS OF VARIABLES AND FUNCTIONS OF VARIABLES
The period over which the means are taken is given by the input parameters, a and b. Sub-vectors of ALLDATA columns are formed containing
the values to to be averaged. In addition, sub-vectors of currents are calculated with sub-vectors of ALLDATA and sub-vectors of effector concentrations
as arguments.  








90The number of points from a to b, including a: 
[Seq.N3] NN1 j2 j1 1
Sub-matrices of effector values from j1 to j2:
[Seq.N4-5] αAA_a_b submatrix αAA j1 j2 0 num_eff_conc 1( ) βAA_a_b submatrix βAA j1 j2 0 num_eff_conc 1( )
[Seq.N6-7] BP_a_b submatrix B_Press j1 j2 0 num_eff_conc 1( ) EETT_a_b submatrix EETT j1 j2 0 num_eff_conc 1( )
[Seq.N8-9] NOX_a_b submatrix NOX j1 j2 0 num_eff_conc 1( ) ATP_a_b submatrix ATPP j1 j2 0 num_eff_conc 1( )
Calculate means of selected variables and steady-state functions.
[Seq.N10] MM
vv submatrix ALLDATA j1 j2 13 num_var i 13 num_var i( )
ca submatrix ALLDATA j1 j2 16 num_var i 16 num_var i( )
na submatrix ALLDATA j1 j2 14 num_var i 14 num_var i( )
kk submatrix ALLDATA j1 j2 15 num_var i 15 num_var i( )
cl submatrix ALLDATA j1 j2 18 num_var i 18 num_var i( )
ca_jun submatrix ALLDATA j1 j2 31 num_var i 31 num_var i( )
ca_nsc_str submatrix ALLDATA j1 j2 60 num_var i 60 num_var i( )
ca_per submatrix ALLDATA j1 j2 33 num_var i 33 num_var i( )
ca_cen submatrix ALLDATA j1 j2 35 num_var i 35 num_var i( )
bk submatrix ALLDATA j1 j2 19 num_var i 19 num_var i( )
bk_pka submatrix ALLDATA j1 j2 20 num_var i 20 num_var i( )
bk_pkc submatrix ALLDATA j1 j2 21 num_var i 21 num_var i( )
bk_pkg submatrix ALLDATA j1 j2 22 num_var i 22 num_var i( )
ryr submatrix ALLDATA j1 j2 23 num_var i 23 num_var i( )
ryr_pka submatrix ALLDATA j1 j2 24 num_var i 24 num_var i( )
ryr_pkc submatrix ALLDATA j1 j2 25 num_var i 25 num_var i( )
cav submatrix ALLDATA j1 j2 26 num_var i 26 num_var i( )
i 0 num_eff_conc 1for
91cav_pkc submatrix ALLDATA j1 j2 27 num_var i 27 num_var i( )
cav_pkg submatrix ALLDATA j1 j2 28 num_var i 28 num_var i( )
serca submatrix ALLDATA j1 j2 29 num_var i 29 num_var i( )
serca_p submatrix ALLDATA j1 j2 30 num_var i 30 num_var i( )
cgmp submatrix ALLDATA j1 j2 42 num_var i 42 num_var i( )
camp submatrix ALLDATA j1 j2 53 num_var i 53 num_var i( )
alpha_ar1 submatrix ALLDATA j1 j2 1 num_var i 1 num_var i( )
gq1_gdp submatrix ALLDATA j1 j2 5 num_var i 5 num_var i( )
gq0_gtp submatrix ALLDATA j1 j2 6 num_var i 6 num_var i( )
plc_pip submatrix ALLDATA j1 j2 10 num_var i 10 num_var i( )
plc_gq0gtp_pip submatrix ALLDATA j1 j2 9 num_var i 9 num_var i( )
dag submatrix ALLDATA j1 j2 12 num_var i 12 num_var i( )
ip3 submatrix ALLDATA j1 j2 11 num_var i 11 num_var i( )
ip3r submatrix ALLDATA j1 j2 58 num_var i 58 num_var i( )
ip3r_irag_pkg submatrix ALLDATA j1 j2 59 num_var i 59 num_var i( )
nakcl submatrix ALLDATA j1 j2 62 num_var i 62 num_var i( )
nakcl_pkc submatrix ALLDATA j1 j2 63 num_var i 63 num_var i( )
pp_nakcl submatrix ALLDATA j1 j2 64 num_var i 64 num_var i( )
pp_p_nakcl submatrix ALLDATA j1 j2 65 num_var i 65 num_var i( )
nsc_str submatrix ALLDATA j1 j2 66 num_var i 66 num_var i( )
nsc_str_pkc submatrix ALLDATA j1 j2 67 num_var i 67 num_var i( )
nsc_str_pkg submatrix ALLDATA j1 j2 68 num_var i 68 num_var i( )
plc_p submatrix ALLDATA j1 j2 69 num_var i 69 num_var i( )
gc0 submatrix ALLDATA j1 j2 37 num_var i 37 num_var i( )
gc1 submatrix ALLDATA j1 j2 38 num_var i 38 num_var i( )
gc2 submatrix ALLDATA j1 j2 39 num_var i 39 num_var i( )
gc1_act submatrix ALLDATA j1 j2 40 num_var i 40 num_var i( )
gc0_p submatrix ALLDATA j1 j2 41 num_var i 41 num_var i( )
βr0 submatrix ALLDATA j1 j2 43 num_var i 43 num_var i( )
βr1 submatrix ALLDATA j1 j2 44 num_var i 44 num_var i( )
βr_p submatrix ALLDATA j1 j2 45 num_var i 45 num_var i( )
βr_in submatrix ALLDATA j1 j2 46 num_var i 46 num_var i( )
g s0 gdp submatrix ALLDATA j1 j2 47 num var i 47 num var i( )
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g_s0_gdp submatrix ALLDATA j1 j2 47 num_var i 47 num_var i( )
g_s1_gdp submatrix ALLDATA j1 j2 48 num_var i 48 num_var i( )
g_s0_gtp submatrix ALLDATA j1 j2 49 num_var i 49 num_var i( )
ac0 submatrix ALLDATA j1 j2 50 num_var i 50 num_var i( )
ac1 submatrix ALLDATA j1 j2 51 num_var i 51 num_var i( )
ac_p submatrix ALLDATA j1 j2 52 num_var i 52 num_var i( )
pde_camp submatrix ALLDATA j1 j2 54 num_var i 54 num_var i( )
pde_camp_p submatrix ALLDATA j1 j2 55 num_var i 55 num_var i( )
pde_cgmp submatrix ALLDATA j1 j2 56 num_var i 56 num_var i( )
pde_cgmp_p submatrix ALLDATA j1 j2 57 num_var i 57 num_var i( )
katp submatrix ALLDATA j1 j2 71 num_var i 71 num_var i( )
katp_pka submatrix ALLDATA j1 j2 72 num_var i 72 num_var i( )
katp_pkcε submatrix ALLDATA j1 j2 73 num_var i 73 num_var i( )
p2xr_0 submatrix ALLDATA j1 j2 74 num_var i 74 num_var i( )
p2xr_3 submatrix ALLDATA j1 j2 75 num_var i 75 num_var i( )
p2xr_3_act submatrix ALLDATA j1 j2 76 num_var i 76 num_var i( )
p2xd_0 submatrix ALLDATA j1 j2 77 num_var i 77 num_var i( )
p2xd_3 submatrix ALLDATA j1 j2 78 num_var i 78 num_var i( )
p2xd_0_pkd submatrix ALLDATA j1 j2 79 num_var i 79 num_var i( )
p2xd_3_pkd submatrix ALLDATA j1 j2 80 num_var i 80 num_var i( )
ii_bk_allj IBK_ALL vvj ca_junj kkj bkj bk_pkaj bk_pkcj bk_pkgj 
ii_cav_allj ICaV_ALL vvj caj cavj cav_pkcj cav_pkgj 
ii_cl_aj IClA vvj ca_nsc_strj clj 
ii_kvj IKv vvj kkj 
ii_all_leakj IALL_leak vvj kkj naj clj caj 
ii_nakj INaK vvj naj kkj 
ii_ncxj INCX vvj caj naj 
ii_nsc_str_allj INSCstr_ALL vvj dagj naj kkj ca_nsc_strj BP_a_bj i nsc_strj nsc_str_pkcj nsc_str_pkgj 
ii_PMCAj IPMCA vvj caj 
ii serca all ISERCA ALL ca ca cen serca serca p 
j 0 j2 j1for
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ii_serca_allj ISERCA_ALL caj ca_cenj sercaj serca_pj 
ii_ryr_allj IRyR_ALL ca_junj ca_perj ryr_pkaj ryr_pkcj 
ii_ip3r_allj IIP3R_ALL caj ip3j ca_cenj ip3rj ip3r_irag_pkgj 
ii_nsc_eet_allj INSCeet_ALL vvj EETT_a_bj i naj kkj ca_junj 
ii_nsc_ne_allj INSCne_ALL vvj dagj naj kkj caj 
ii_nak_clj INaK_Cl nakclj nakcl_pkcj naj kkj clj 
rel_pkcj relPKC11 dagj caj 
rel_pkaj relPKA1 campj 
rel_pkgj relPKG1 cgmpj 
rel_pkcεj relPKCεDAG dagj 
rel_pkdj relPKDDAG dagj 
ii_katp_allj IKATP_ALL vvj kkj katpj katp_pkaj 
ii_p2xr_allj IP2XR_ALL vvj naj kkj caj p2xr_3_actj 
ii_ca_p2xrj ICaP2XR vvj caj p2xr_3_actj 
ii_ca_leakj ICa_leak vvj caj 
ii_cl_leakj ICl_leak vvj clj 
ii_kk_leakj IK_leak vvj kkj 
MEANi 0 mean vv( )
MEANi 1 mean ca( )
MEANi 2 mean ca_nsc_str( )
MEANi 3 mean ca_jun( )
MEANi 4 mean ii_bk_all( )
MEANi 5 mean ii_cav_all( )
MEANi 6 mean ii_cl_a( )
MEANi 7 mean ii_kv( )
94MEANi 8 mean ii_all_leak( )
MEANi 9 mean ii_nak( )
MEANi 10 mean ii_ncx( )
MEANi 11 mean ii_nsc_str_all( )
MEANi 12 mean ii_PMCA( )
MEANi 13 mean ii_serca_all( )
MEANi 14 mean ii_ryr_all( )
MEANi 15 mean ca_per( )
MEANi 16 mean ca_cen( )
MEANi 17 mean cl( )
MEANi 18 mean kk( )
MEANi 19 mean na( )
MEANi 20 mean ii_ca_leak( )
MEANi 21 mean ii_ip3r_all( )
MEANi 22 mean ii_nsc_eet_all( )
MEANi 23 mean ii_nsc_ne_all( )
MEANi 24 mean ii_nak_cl( )
MEANi 25 mean alpha_ar1( )
MEANi 26 mean gq1_gdp( )
MEANi 27 mean gq0_gtp( )
MEANi 28 mean plc_pip( )
MEANi 29 mean ip3( )
MEANi 30 mean dag( )
MEANi 31 mean rel_pkc( )
MEANi 32 mean plc_gq0gtp_pip( )
95MEANi 33 mean plc_p( )
MEANi 34 mean gc0( )
MEANi 35 mean gc1( )
MEANi 36 mean gc2( )
MEANi 37 mean gc1_act( )
MEANi 38 mean gc0_p( )
MEANi 39 mean cgmp( )
MEANi 40 mean βr0( )
MEANi 41 mean βr1( )
MEANi 42 mean βr_p( )
MEANi 43 mean βr_in( )
MEANi 44 mean g_s0_gdp( )
MEANi 45 mean g_s1_gdp( )
MEANi 46 mean g_s0_gtp( )
MEANi 47 mean ac0( )
MEANi 48 mean ac1( )
MEANi 49 mean ac_p( )
MEANi 50 mean camp( )
MEANi 51 mean pde_camp( )
MEANi 52 mean pde_camp_p( )
MEANi 53 mean pde_cgmp( )
MEANi 54 mean pde_cgmp_p( )
MEANi 55 mean rel_pka( )
MEANi 56 mean rel_pkg( )
MEANi 57 mean bk( )
96MEANi 58 mean bk_pka( )
MEANi 59 mean bk_pkc( )
MEANi 60 mean bk_pkg( )
MEANi 61 mean cav( )
MEANi 62 mean cav_pkc( )
MEANi 63 mean cav_pkg( )
MEANi 64 mean ii_cl_leak( )
MEANi 65 mean nakcl( )
MEANi 66 mean nakcl_pkc( )
MEANi 67 mean nsc_str( )
MEANi 68 mean nsc_str_pkc( )
MEANi 69 mean nsc_str_pkg( )
MEANi 70 mean pp_nakcl( )
MEANi 71 mean pp_p_nakcl( )
MEANi 72 mean ip3r( )
MEANi 73 mean ip3r_irag_pkg( )
MEANi 74 mean serca( )
MEANi 75 mean serca_p( )
MEANi 76 mean rel_pkcε( )
MEANi 77 mean katp( )
MEANi 78 mean katp_pka( )
MEANi 79 mean katp_pkcε( )
MEANi 80 mean ii_katp_all( )
MEANi 81 mean rel_pkd( )
MEANi 82 mean p2xr_0( )
97
i 82
MEANi 83 mean p2xr_3( )
MEANi 84 mean p2xr_3_act( )
MEANi 85 mean p2xd_0( )
MEANi 86 mean p2xd_3( )
MEANi 87 mean p2xd_0_pkd( )
MEANi 88 mean p2xd_3_pkd( )
MEANi 89 mean ii_p2xr_all( )
MEANi 90 mean ii_ca_p2xr( )
MEANi 91 mean ii_kk_leak( )
MEAN
The transposed matrix of means from a run is copied to Excel file aligned with the
parameters of the run. 
T








-6.1724E+001 -5.9241E+001 -5.1801E+001 -4.5342E+001 -4.0469E+001
1.2166E-001 1.3199E-001 1.6264E-001 1.947E-001 2.2091E-001
1.5074E-001 2.0375E-001 3.5952E-001 5.3243E-001 6.8262E-001
2.3747E-001 3.6341E-001 5.1121E-001 7.003E-001 8.4063E-001
3.0989E-002 1.4031E-001 1.0896E+000 2.3384E+000 3.7859E+000
-3.3269E-001 -4.698E-001 -9.453E-001 -1.6404E+000 -2.3561E+000











3.7951E-002 8.9672E-002 3.9222E-001 1.1312E+000 2.1059E+000
-4.1204E-001 -3.8268E-001 -2.9295E-001 -2.0594E-001 -1.3674E-001
7.2104E-001 7.5714E-001 8.4594E-001 9.7927E-001 1.1312E+000
-8.5613E-002 -8.9856E-002 -9.8867E-002 -9.376E-002 -7.9484E-002
-1.3542E-002 -3.3336E-002 -9.0782E-002 -1.5453E-001 -2.1015E-001
1.931E-001 2.5382E-001 4.8358E-001 8.3392E-001 1.2038E+000
2.6346E-002 3.5044E-002 5.0047E-002 6.8173E-002 8.1635E-002
-1.7878E-002 -3.5637E-002 -5.4534E-002 -7.7982E-002 -9.5826E-002
1.3517E+002 1.1268E+002 9.987E+001 8.2321E+001 7.2116E+001
1.4096E+002 1.2428E+002 1.1698E+002 1.0762E+002 ...

Define vectors for plotting means
[Seq.N12-16] meanV MM 0
 
 meanCa_in MM 1
 
 meanCa_NSCstr MM 2
 
 meanCa_jun MM 3
 
 meanI_BK_ALL MM 4
 

[Seq.N17-21] meanI_CaV_ALL MM 5
 
 meanI_ClA MM 6
 
 meanI_Kv MM 7
 
 meanI_ALL_leak MM 8
 
 meanI_NaK MM 9
 

[Seq.N22-26] meanI_NCX MM 10
 
 meanI_NSCstr_ALL MM 11
 
 meanI_PMCA MM 12
 
 meanI_SERCA_ALL MM 13
 
 meanI_RyR_ALL MM 14
 

[Seq.N27-31] meanCa_SRper MM 15
 
 meanCa_SRcen MM 16
 
 meanCl_in MM 17
 
 meanK_in MM 18
 
 meanNa_in MM 19
 

[Seq.N32-36] meanI_Ca_leak MM 20
 
 meanI_IP3R_ALL MM 21
 




 meanI_NaK_Cl MM 24
 

[Seq.N37-41] mean_αAR1 MM 25
 
 meanIP3 MM 29
 
 meanGq0_GTP MM 27
 
 meanPLC_PIP MM 28
 
 meanGq1_GDP MM 26
 

[Seq.N42-45] meanDAG MM 30
 
 meanPLC_Gq0_GTP_PIP MM 32
 





[Seq.N46-50] meanGC_0 MM 34
 
 meanGC_1 MM 35
 
 meanGC_2 MM 36
 
 meanGC_1_act MM 37
 
 meanGC_0P MM 38
 

[Seq.N51-55] mean_cGMP MM 39
 
 mean_βAR_0 MM 40
 
 mean_βAR_1 MM 41
 
 mean_βAR_P MM 42
 




[Seq.N56-60] meanGs0_GDP MM 44
 
 meanGs1_GDP MM 45
 
 meanGs0_GTP MM 46
 
 meanAC_0 MM 47
 
 meanAC_1 MM 48
 

[Seq.N61-65] meanAC_P MM 49
 
 mean_cAMP MM 50
 
 meanPDE_cAMP MM 51
 
 meanPDE_cAMP_P MM 52
 
 mean_PDE_cGMP MM 53
 

[Seq.N66-70] meanPDE_cGMP_P MM 54
 
 mean_rel_PKA MM 55
 
 mean_rel_PKG MM 56
 
 mean_rel_PKCε MM 76
 
 mean_rel_PKD MM 81
 

[Seq.N71-75] meanK_ATP MM 77
 
 meanK_ATP_PKA MM 78
 
 meanK_ATP_PKCε MM 79
 
 meanI_KATP_ALL MM 80
 
 meanI_Cl_leak MM 64
 

[Seq.N76-80] meanP2XR_0 MM 82
 
 meanP2XR_3 MM 83
 
 meanP2XR_3_act MM 84
 
 meanP2XD_0 MM 85
 
 meanP2XD_3 MM 86
 

[Seq.N81-85] meanP2XD_0_PKD MM 87
 
 meanP2XD_3_PKD MM 88
 
 meanI_P2XR_ALL MM 89
 
 meanI_CaP2XR MM 90
 
 meanI_K_leak MM 91
 

P. PLOTS OF SOME MEANS VERSUS INTRAVASCULAR PRESSURES or EFFECTOR CONCENTRATIONS
(Membrane potential is in mV; Ca concentrations are in μM; Na, K, and Cl concentrations are in mM; currents are in pA; intravascular pressure,
bp1, is in mm mg.)
[Splot P1-3]
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[Splot P31-33]
